[go: up one dir, main page]

WO2015111942A2 - Organic compound and organic electroluminescent element comprising same - Google Patents

Organic compound and organic electroluminescent element comprising same Download PDF

Info

Publication number
WO2015111942A2
WO2015111942A2 PCT/KR2015/000699 KR2015000699W WO2015111942A2 WO 2015111942 A2 WO2015111942 A2 WO 2015111942A2 KR 2015000699 W KR2015000699 W KR 2015000699W WO 2015111942 A2 WO2015111942 A2 WO 2015111942A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
synthesis
mol
indole
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2015/000699
Other languages
French (fr)
Korean (ko)
Other versions
WO2015111942A3 (en
Inventor
엄민식
김회문
박성진
이창준
신진용
김태형
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Doosan Corp
Original Assignee
Doosan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doosan Corp filed Critical Doosan Corp
Publication of WO2015111942A2 publication Critical patent/WO2015111942A2/en
Publication of WO2015111942A3 publication Critical patent/WO2015111942A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1048Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1051Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/10Triplet emission
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium

Definitions

  • the present invention relates to an organic compound and an organic electroluminescent device comprising the same.
  • the organic electroluminescent device when a voltage is applied between two electrodes, holes are injected into the organic material layer at the anode, and electrons are injected into the organic material layer at the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall to the ground, they shine.
  • the material included in the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material, and the like according to its function.
  • the light emitting material may be classified into blue, green, and red light emitting materials according to the light emitting color, and yellow and orange light emitting materials required to realize a better natural color.
  • a host / dopant system may be used as a light emitting material to increase luminous efficiency through an increase in color purity and energy transfer.
  • the dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt.
  • a metal complex compound containing heavy atoms such as Ir and Pt.
  • anthracene derivatives are known as fluorescent dopant / host materials used in the light emitting layer.
  • a phosphorescent dopant material used in the light emitting layer metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 are known, and as a phosphorescent host material, 4,4-dicarbazolybiphenyl (CBP) is known.
  • the existing materials are not satisfactory in terms of lifespan of the organic EL device due to low thermal stability due to low glass transition temperature, and still need improvement in terms of emission characteristics.
  • an object of the present invention is to provide an organic compound having a high glass transition temperature and excellent thermal stability and luminescence properties.
  • an object of this invention is to provide the organic electroluminescent element containing the said organic compound.
  • the present invention provides a compound represented by the following formula (1).
  • X 1 is selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ),
  • X 2 and X 3 are each independently N or C (R 2 ),
  • Y 1 to Y 4 are each independently N or C (R 1 ), and at least one of Y 1 and Y 2 , Y 2 and Y 3, and Y 3 and Y 4 forms a condensed ring represented by Formula 2 below. and,
  • Dotted line is a portion that is bonded to the compound of Formula 1,
  • X 4 is selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ),
  • Y 5 to Y 8 are each independently N or C (R 3 ),
  • At least one of X 1 and X 4 is N (Ar 1 ),
  • R 1 to R 3 and Ar 1 to Ar 5 are each independently, hydrogen, deuterium, halogen group, nitro group, amino group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 to C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 to C 40 Alkyloxy group, C 6 ⁇ C 60 aryloxy group, C 1 ⁇ C 40 alkylsilyl group, C 6 ⁇ C 60 arylsilyl group, C 1 ⁇ C 40 alkyl boron group, C 6 ⁇ C 60 the arylboronic group, C 1 ⁇ C 40 of the phosphine group, is selected from the group consisting of an aryl amine of the C 1 ⁇ C 40 phosphine oxide group, and a C 6 ⁇ C 60 of the,
  • R 1 to R 3 form or not form a condensed ring with an adjacent group
  • Alkyl boron group, aryl boron group, phosphine group, phosphine oxide group and arylamine group are each independently deuterium, halogen group, nitro group, amino group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group , C 2 ⁇ C 40 Alkynyl group, C 3 ⁇ C 40 Cycloalkyl group, C 3 ⁇ C 40 heterocycloalkyl group, C 6 ⁇ C 60 Aryl group, Nuclear atoms 5 to 60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 1
  • the present invention is an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, at least one of the at least one organic layer is a compound represented by the formula (1) It provides an organic electroluminescent device comprising.
  • Alkyl in the present invention means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl and the like.
  • Alkenyl in the present invention means a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.
  • Alkynyl in the present invention means a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.
  • Aryl in the present invention means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms combined with a single ring or two or more rings. It may also include a form in which two or more rings are attached to each other (pendant) or condensed. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
  • Heteroaryl in the present invention means a monovalent substituent derived from monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms. At least one carbon in the ring, preferably 1 to 3 carbons, is substituted with a heteroatom such as N, O, S or Se.
  • a form in which two or more rings are attached to each other (pendant) or condensed may also be included, and may also include a form condensed with an aryl group.
  • heteroaryl examples include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolinzinyl, indolyl ( polycyclic rings such as indolyl, purinyl, quinolyl, benzothiazole, carbazolyl and 2-furanyl, N-imidazolyl, 2-isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like, but are not limited thereto.
  • 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolinzinyl, indolyl ( polycyclic rings such as indolyl, purinyl, quinolyl, benzothiazole, carb
  • Aryloxy in the present invention is a monovalent substituent represented by RO-, wherein R means aryl having 6 to 60 carbon atoms.
  • R means aryl having 6 to 60 carbon atoms.
  • Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.
  • Alkyloxy in the present invention is a monovalent substituent represented by R'O-, wherein R 'means an alkyl having 1 to 40 carbon atoms, and a linear, branched or cyclic structure It may include.
  • alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
  • Arylamine in the present invention means an amine substituted with aryl having 6 to 60 carbon atoms.
  • Cycloalkyl in the present invention means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms.
  • Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
  • Heterocycloalkyl in the present invention means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, wherein at least one carbon in the ring, preferably 1 to 3 carbons is N, O, S or Substituted with a hetero atom such as Se.
  • heterocycloalkyl include, but are not limited to, morpholine, piperazine, and the like.
  • Alkylsilyl in the present invention is silyl substituted with alkyl having 1 to 40 carbon atoms
  • arylsilyl means silyl substituted with aryl having 6 to 60 carbon atoms.
  • the condensed ring means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
  • the organic compound of the present invention is a structure in which two indene moieties containing one or more heteroatoms such as N, O, and S are fused to each other to form a basic skeleton, and various substituents are bonded to each other. Is displayed.
  • the host In the phosphorescent layer of the organic EL device, the host should have a triplet energy gap higher than that of the dopant. That is, in order to effectively provide phosphorescence from the dopant, the energy of the lowest excited state of the host must be higher than the energy of the lowest emission state of the dopant.
  • the compound represented by Formula 1 may exhibit a higher energy level than the dopant when used as a host because a specific substituent is introduced into the indene moiety having a wide singlet energy level and a high triplet energy level.
  • the compound represented by the formula (1) of the present invention includes at least one or more C 6 ⁇ C 60 aryl group substituted with a cyano group or at least one heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group Since it has a bipolar characteristic, when the host is used, the binding force between the holes and the electrons in the emission layer may be increased.
  • the compound represented by Chemical Formula 1 of the present invention prevents the excitons generated in the light emitting layer from diffusing to the adjacent electron transport layer or the hole transport layer, thereby increasing the number of excitons that contribute to the light emission, so that the light emission efficiency when used in the light emitting auxiliary layer In addition, the life of the organic EL device can be improved.
  • the compound represented by the general formula (1) of the present invention exhibits a high glass transition temperature by introducing various substituents, especially aryl groups and / or heteroaryl groups, thereby significantly increasing the molecular weight of the compound. , CBP) can have better thermal stability.
  • the compound represented by the formula (1) is effective in suppressing the crystallization of the organic material layer.
  • the performance and lifespan characteristics of the organic EL device may be greatly improved.
  • the lifespan of the organic EL device may maximize the performance of the full color OLED panel.
  • Such a compound represented by Formula 1 of the present invention may be embodied as a compound represented by the following formula (1a to 1f).
  • Y 1 to Y 4 are N or C (R 1 ), all of which are preferably C (R 1 ), and Y 5 to Y 8 are N or C (R 3 ), all of which are C that the (R 3) are preferred.
  • R 1 and R 3 are the same or different from each other.
  • the compound represented by Chemical Formula 1 of the present invention may be further embodied by the compounds represented by the following Chemical Formulas B-1 to B-30, but is not limited thereto.
  • Ar 1 and R 1 to R 3 are the same as defined in Formula 1.
  • a plurality of R 1 is the same or different from each other
  • a plurality of R 2 is the same or different from each other
  • a plurality of R 3 is the same or different from each other.
  • R 1 to R 3 and Ar 1 to Ar 5 are each independently hydrogen, deuterium, a halogen group, a nitro group, an amino group, an alkyl group of C 1 to C 40 , and C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 alkynyl group, C 3 ⁇ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ⁇ C 60 aryl group, the number of nuclear atoms of 5 to the 60 heteroaryl group, C 1 to C 40 alkyloxy group, C 6 to C 60 aryloxy group, C 1 to C 40 alkylsilyl group, C 6 to C 60 arylsilyl group, C 1 to C 40 groups of an alkyl boron, an aryl boronic of C 6 ⁇ C 60, C 1 ⁇ C 40 phosphine group, C 1 ⁇ C 40 phosphine oxide group, and
  • R 1 to R 3 are each independently hydrogen, halogen, cyano group, C 1 ⁇ C 40 alkyl group, C 6 ⁇ C 60 aryl group, nuclear atoms 5 to 60 heteroaryl group and C 6 ⁇ C It is preferably selected from the group consisting of 60 arylamine groups,
  • Ar 1 to Ar 5 are each independently composed of a C 6 ⁇ C 60 aryl group, a heteroaryl group of 5 to 60 nuclear atoms, a C 6 ⁇ C 60 arylamine group and a C 6 ⁇ C 60 arylsilyl group It is preferably selected from the group.
  • R 1 to R 3 and Ar 1 to Ar 5 is a C 6 ⁇ C 60 aryl group substituted with a cyano group or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group
  • Ar 1 is a C 6 to C 60 aryl group substituted with a cyano group or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group.
  • R 1 to R 3 and Ar 1 to Ar 5 may each independently be selected from hydrogen or a substituent consisting of S1 to S204, or a substituent including one or more cyano groups in the selected substituent (bonded) have.
  • the compound represented by the formula (1) of the present invention can be synthesized in various ways with reference to the following synthesis examples.
  • the present invention provides an organic electroluminescent device comprising a compound represented by the formula (1).
  • the present invention includes an anode, a cathode and at least one organic material layer interposed between the anode and the cathode, at least one of the organic material layer comprises an organic electric field comprising at least one compound represented by the formula (1)
  • a light emitting device Provided is a light emitting device.
  • the organic material layer including the compound represented by Chemical Formula 1 may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer.
  • the compound represented by Formula 1 may be included in the organic electroluminescent device as a light emitting layer material.
  • the organic EL device may improve luminous efficiency, brightness, power efficiency, thermal stability, and device life.
  • the compound represented by Formula 1 of the present invention is preferably a phosphorescent host, a fluorescent host or a dopant material of the light emitting layer, and more preferably a phosphorescent host material of the light emitting layer.
  • the structure of the organic EL device of the present invention is not particularly limited, but a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode may be sequentially stacked.
  • An electron injection layer may be inserted on the electron transport layer.
  • An insulating layer or an adhesive layer may be inserted between the electrode and the organic material layer interface.
  • the organic material layer including the compound represented by Chemical Formula 1 may be formed by a vacuum deposition method or a solution coating method.
  • the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
  • the organic electroluminescent device of the present invention may be manufactured by forming an organic material layer and an electrode using materials and methods known in the art, except that at least one layer of the organic material layer is formed to include the compound represented by Chemical Formula 1. have.
  • a silicon wafer, a quartz or glass plate, a metal plate, a plastic film, or the like may be used as the substrate.
  • the anode material may be a metal such as vanadium, chromium, copper, zinc, gold or an alloy thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black may be used, but is not limited thereto.
  • Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb
  • Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (
  • the negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof;
  • a multilayer structure material such as LiF / Al or LiO 2 / Al may be used, but is not limited thereto.
  • the material used as the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer is not particularly limited as long as it is a conventional material known in the art.
  • PC-2 was obtained by the same procedure as in ⁇ Step 4> of Preparation Example 1 using 5- (2-nitrophenyl) -1-phenyl-1H-indole, triphenylphosphine and 1,2-dichlorobenzene.
  • 6- (4,4,5,5-tetramethyl- obtained in ⁇ Step 1> instead of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole Except for using 1,3,2-dioxaborolan-2-yl) -1H-indole, 6- (2-nitrophenyl) -1H-indole was prepared in the same manner as in ⁇ Step 2> of Preparation Example 1. Got it.
  • 6-chloro-1H-indole 25 g, 0.17 mol
  • bromobenzene 31.19 g, 0.20 mol
  • Pd (OAc) 2 (1.86 g, 5 mol)
  • Triphenylphosphine (2.17 g, 5 mol%)
  • K 2 CO 3 68.64 g, 0.50 mol
  • 1,4-dioxane 300 ml
  • 6-bromo-1H-indazole instead of 5-bromo-1H-indazole, 6- (4,4,5,5-tetramethyl- was carried out in the same manner as in ⁇ Step 1> of Preparation Example 14 above. 1,3,2-dioxaborolan-2-yl) -1H-indazole was obtained.
  • 6- (2-nitrophenyl) -1H-indazole instead of 5- (2-nitrophenyl) -1H-indazole, 6- (2- nitrophenyl) -1-phenyl-1H-indole was obtained.
  • N- (2,4-dibromophenyl) benzamide 251.1 g, 710 mmol
  • K 2 CO 3 (196.3 g, 1420 mmol)
  • DMSO 7100 ml
  • 6-bromo-2-phenylbenzo [d] oxazole (147.9 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h.
  • 6-bromo-2-phenylbenzo [d] thiazole (156.6 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h.
  • PC-1 (3 g, 10.63 mmol), 3'-Bromo-biphenyl-4-carbonitrile (2.89 g, 11.20 mmol), Pd (OAc) 2 (0.12 g, 5 mol%), NaO (t-) under nitrogen stream bu) (2.04 g, 21.25 mmol), P (t-bu) 3 (0.21 g, 1.06 mmol) and Toluene (100 ml) were mixed and stirred at 110 ° C. for 12 h.
  • the target compound was prepared in the same manner as in Synthesis Example 1, except that PC-5 and 8-Bromo-dibenzothiophene-2-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. 6 (3.28 g, 63%) was obtained.
  • Inv-9 (5.59 g, 75%) was obtained by the same procedure as in Synthesis Example 8, except that 9-phenyl-9H-carbazol-3-ylboronic acid was used instead of phenylboronic acid.
  • Inv-12 (3.32 g) was prepared by the same procedure as in Synthesis Example 1, except that PC-9 and 4-Bromo-benzonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. , 68%).
  • Inv-16 (3.47 g) was prepared by the same procedure as in Synthesis Example 1, except that PC-13 and 3-Bromo-benzonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. , 61%).
  • a target compound was prepared in the same manner as in Synthesis Example 1, except that IC-2 and 4'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -19 (4.01 g, 82%) was obtained.
  • a target compound was prepared in the same manner as in Synthesis Example 1, except that BOC-1 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -24 (3.53, 72%) was obtained.
  • a target compound was prepared in the same manner as in Synthesis Example 1, except that BOC-3 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -28 (4.29, 75%) was obtained.
  • a target compound was prepared in the same manner as in Synthesis Example 1, except that BTC-1 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -37 (3.81, 75%) was obtained.
  • a target compound was prepared in the same manner as in Synthesis Example 1, except that BTC-3 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -41 (4.47, 76%).
  • the compound synthesized in Synthesis Example was subjected to high purity sublimation purification by a conventionally known method, and the device was manufactured according to the following procedure.
  • a glass substrate coated with ITO Indium tin oxide
  • ITO Indium tin oxide
  • a solvent such as isopropyl alcohol, acetone, methanol, etc.
  • UV OZONE cleaner Power sonic 405, Hwasin Tech
  • M-MTDATA 60 nm) / TCTA (80 nm) / 90% Inv-1 to Inv-48 compound + 10% Ir (ppy) 3 (30 nm) / BCP (ITO transparent substrate (electrode) thus prepared) 10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) was laminated in order to manufacture a device.
  • a device was manufactured in the same manner as in Example 1, except for using CBP instead of the compound Inv-1 as a light emitting host material when forming the emission layer.
  • Example 1 Sample Host Driving voltage (V) Light emitting peak (nm) Current efficiency (cd / A) Example 1 Inv-1 6.66 516 42.6 Example 2 Inv-2 6.91 517 39.4 Example 3 Inv-3 6.85 516 38.8 Example 4 Inv-4 6.86 516 43.5 Example 5 Inv-5 6.91 517 42.1 Example 6 Inv-6 6.85 516 42.6 Example 7 Inv-7 6.63 515 39.4 Example 8 Inv-8 6.75 515 38.8 Example 9 Inv-9 6.85 516 40.9 Example 10 Inv-10 6.63 517 42.1 Example 11 Inv-11 6.75 516 42.6 Example 12 Inv-12 6.73 517 39.4 Example 13 Inv-13 6.75 515 38.8 Example 14 Inv-14 6.63 516 40.9 Example 15 Inv-15 6.75 517 41.2 Example 16 Inv-16 6.73 516 39.2 Example 17 Inv-17 6.75 517 41.1 Example 18 Inv-18 6.81 517 42.0 Example 19 Inv-19 6.89 517 41.1 Example 20 Inv-20 6.81 518 4
  • the compound of the present invention has excellent thermal stability, electron and hole transport ability, light emitting ability, and the like, it can be usefully applied as an organic material layer material of an organic EL device.
  • the organic electroluminescent device including the compound of the present invention in the organic material layer can be effectively applied to a full color display panel since the aspects such as light emission performance, driving voltage, lifetime, and efficiency are greatly improved.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to an organic compound and an organic electroluminescent element comprising the same, and the organic compound of the present invention is used for an organic material layer, preferably, a light emission layer, of the organic electroluminescent element, and thus can improve the light emission efficiency, driving voltage, lifetime, and the like of the organic electroluminescent element.

Description

유기 화합물 및 이를 포함하는 유기 전계 발광 소자Organic compound and organic electroluminescent device comprising the same

본 발명은 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것이다.The present invention relates to an organic compound and an organic electroluminescent device comprising the same.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 상기 유기물층에 포함되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic material layer at the anode, and electrons are injected into the organic material layer at the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall to the ground, they shine. The material included in the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material, and the like according to its function.

상기 발광 물질은 발광색에 따라 청색, 녹색, 적색의 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색의 발광 물질로 구분될 수 있다. 또한 색순도의 증가와 에너지 전이를 통해 발광 효율을 증가시키기 위하여 발광 물질로서 호스트/도판트 계를 사용할 수 있다.The light emitting material may be classified into blue, green, and red light emitting materials according to the light emitting color, and yellow and orange light emitting materials required to realize a better natural color. In addition, a host / dopant system may be used as a light emitting material to increase luminous efficiency through an increase in color purity and energy transfer.

도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때 인광 도판트는 이론적으로 형광 도판트에 비해 최대 4배의 발광 효율을 향상시킬 수 있기 때문에 인광 도판트 뿐만 아니라 인광 호스트에 대한 연구가 많이 진행되고 있다.The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. In this case, since phosphorescent dopants can theoretically improve luminous efficiency up to 4 times compared to fluorescent dopants, studies on phosphorescent dopants as well as phosphorescent hosts are being conducted.

현재 발광층에 사용되는 형광 도판트/호스트 물질로는 안트라센 유도체들이 알려져 있다. 또한 발광층에 사용되는 인광 도판트 물질로는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등의 Ir을 포함하는 금속 착체 화합물이 알려져 있고, 인광 호스트 물질로는 4,4-dicarbazolybiphenyl(CBP)가 알려져 있다.At present, anthracene derivatives are known as fluorescent dopant / host materials used in the light emitting layer. In addition, as a phosphorescent dopant material used in the light emitting layer, metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 are known, and as a phosphorescent host material, 4,4-dicarbazolybiphenyl (CBP) is known.

그러나 기존의 재료들은 유리전이온도가 낮아 열적 안정성이 떨어지기 때문에 유기 전계 발광 소자의 수명 측면에서 만족할 만한 수준이 되지 못하고 있으며, 발광 특성 측면에서도 여전히 개선이 필요하다.However, the existing materials are not satisfactory in terms of lifespan of the organic EL device due to low thermal stability due to low glass transition temperature, and still need improvement in terms of emission characteristics.

상기한 문제점을 해결하기 위해 본 발명은 유리전이온도가 높으며 열적 안정성 및 발광 특성이 우수한 유기 화합물을 제공하는 것을 목적으로 한다.In order to solve the above problems, an object of the present invention is to provide an organic compound having a high glass transition temperature and excellent thermal stability and luminescence properties.

또 본 발명은 상기 유기 화합물을 포함하는 유기 전계 발광 소자를 제공하는 것도 목적으로 한다.Moreover, an object of this invention is to provide the organic electroluminescent element containing the said organic compound.

상기한 목적을 달성하기 위해 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to achieve the above object, the present invention provides a compound represented by the following formula (1).

[화학식 1][Formula 1]

Figure PCTKR2015000699-appb-I000001
Figure PCTKR2015000699-appb-I000001

상기 화학식 1에서,In Chemical Formula 1,

X1은 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고,X 1 is selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ),

X2 및 X3는 각각 독립적으로, N 또는 C(R2)이며,X 2 and X 3 are each independently N or C (R 2 ),

Y1 내지 Y4는 각각 독립적으로, N 또는 C(R1)이되, Y1과 Y2, Y2와 Y3 및 Y3와 Y4 중 적어도 하나는 하기 화학식 2로 표시되는 축합 고리를 형성하고,Y 1 to Y 4 are each independently N or C (R 1 ), and at least one of Y 1 and Y 2 , Y 2 and Y 3, and Y 3 and Y 4 forms a condensed ring represented by Formula 2 below. and,

[화학식 2][Formula 2]

Figure PCTKR2015000699-appb-I000002
Figure PCTKR2015000699-appb-I000002

상기 화학식 2에서,In Chemical Formula 2,

점선은 상기 화학식 1의 화합물과 결합되는 부분이고,Dotted line is a portion that is bonded to the compound of Formula 1,

X4는 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고,X 4 is selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ),

Y5 내지 Y8은 각각 독립적으로, N 또는 C(R3)이고,Y 5 to Y 8 are each independently N or C (R 3 ),

상기 X1 및 X4 중 적어도 하나는 N(Ar1)이며,At least one of X 1 and X 4 is N (Ar 1 ),

상기 R1 내지 R3 및 Ar1 내지 Ar5는 각각 독립적으로, 수소, 중수소, 할로겐기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C1~C40의 포스핀기, C1~C40의 포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 이때, R1 내지 R3 및 Ar1 내지 Ar5 중 적어도 하나는 시아노기가 치환된 C6~C60의 아릴기 또는 시아노기가 치환된 핵원자수 5 내지 60의 헤테로아릴기이며,Wherein R 1 to R 3 and Ar 1 to Ar 5 are each independently, hydrogen, deuterium, halogen group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 to C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 to C 40 Alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 the arylboronic group, C 1 ~ C 40 of the phosphine group, is selected from the group consisting of an aryl amine of the C 1 ~ C 40 phosphine oxide group, and a C 6 ~ C 60 of the, at this time, R 1 to R 3 and Ar 1 At least one of Ar 5 is a C 6 ~ C 60 Aryl group substituted with a cyano group or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group,

상기 R1 내지 R3는 인접한 기와 축합 고리를 형성 또는 비형성하고,R 1 to R 3 form or not form a condensed ring with an adjacent group,

상기 R1 내지 R3 및 Ar1 내지 Ar5의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 포스핀기, 포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C1~C40의 포스핀기, C1~C40의 포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환 또는 비치환된다. 여기서 R1 내지 R3 및 Ar1 내지 Ar5이 복수의 치환기로 치환될 경우, 복수의 치환기는 서로 동일하거나 상이하다.The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group of R 1 to R 3 and Ar 1 to Ar 5 , Alkyl boron group, aryl boron group, phosphine group, phosphine oxide group and arylamine group are each independently deuterium, halogen group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group , C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 Cycloalkyl group, C 3 ~ C 40 heterocycloalkyl group, C 6 ~ C 60 Aryl group, Nuclear atoms 5 to 60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 1 -C 40 alkylsilyl group, C 6 -C 60 arylsilyl group, C 1 -C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 1 ~ C 40 of the phosphine group, C 1 ~ C 40 phosphine oxide group, and a C 6 ~ substituted by one or more selected from the group consisting of an aryl amine of the C 60 of the Or unsubstituted. Wherein when R 1 to R 3 and Ar 1 to Ar 5 are substituted with a plurality of substituents, the plurality of substituents are the same or different from each other.

한편 본 발명은 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.On the other hand, the present invention is an organic electroluminescent device comprising an anode, a cathode, and at least one organic layer interposed between the anode and the cathode, at least one of the at least one organic layer is a compound represented by the formula (1) It provides an organic electroluminescent device comprising.

본 발명에서의 알킬은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다.Alkyl in the present invention means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl and the like.

본 발명에서의 알케닐(alkenyl)은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.Alkenyl in the present invention means a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.

본 발명에서의 알키닐(alkynyl)은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있으나, 이에 한정되지는 않는다.Alkynyl in the present invention means a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.

본 발명에서의 아릴은 단독 고리 또는 2 이상의 고리가 조합된 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있으나, 이에 한정되지는 않는다.Aryl in the present invention means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms combined with a single ring or two or more rings. It may also include a form in which two or more rings are attached to each other (pendant) or condensed. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.

본 발명에서의 헤테로아릴은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함될 수 있다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리, 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있으나, 이에 한정되지는 않는다.Heteroaryl in the present invention means a monovalent substituent derived from monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms. At least one carbon in the ring, preferably 1 to 3 carbons, is substituted with a heteroatom such as N, O, S or Se. In addition, a form in which two or more rings are attached to each other (pendant) or condensed may also be included, and may also include a form condensed with an aryl group. Examples of such heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolinzinyl, indolyl ( polycyclic rings such as indolyl, purinyl, quinolyl, benzothiazole, carbazolyl and 2-furanyl, N-imidazolyl, 2-isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like, but are not limited thereto.

본 발명에서의 아릴옥시는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 6 내지 60의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있으나, 이에 한정되지는 않는다.Aryloxy in the present invention is a monovalent substituent represented by RO-, wherein R means aryl having 6 to 60 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.

본 발명에서의 알킬옥시는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 탄소수 1 내지 40의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 이러한 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있으나, 이에 한정되지는 않는다.Alkyloxy in the present invention is a monovalent substituent represented by R'O-, wherein R 'means an alkyl having 1 to 40 carbon atoms, and a linear, branched or cyclic structure It may include. Examples of such alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.

본 발명에서의 아릴아민은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.Arylamine in the present invention means an amine substituted with aryl having 6 to 60 carbon atoms.

본 발명에서의 시클로알킬은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 시클로알킬의 예로는 시클로프로필, 시클로펜틸, 시클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있으나, 이에 한정되지는 않는다.Cycloalkyl in the present invention means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.

본 발명에서의 헤테로시클로알킬은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있으나, 이에 한정되지는 않는다.Heterocycloalkyl in the present invention means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, wherein at least one carbon in the ring, preferably 1 to 3 carbons is N, O, S or Substituted with a hetero atom such as Se. Examples of such heterocycloalkyl include, but are not limited to, morpholine, piperazine, and the like.

본 발명에서의 알킬실릴은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, 아릴실릴은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미한다.Alkylsilyl in the present invention is silyl substituted with alkyl having 1 to 40 carbon atoms, arylsilyl means silyl substituted with aryl having 6 to 60 carbon atoms.

본 발명에서 축합고리는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, the condensed ring means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.

이하, 본 발명을 설명한다.Hereinafter, the present invention will be described.

1. 신규 유기 화합물1. New Organic Compounds

본 발명의 유기 화합물은 N, O, S 등의 헤테로원자를 1개 이상 함유하는 2개의 인덴 모이어티가 서로 축합(fused)되어 기본 골격을 이루며, 다양한 치환체가 결합된 구조로서, 상기 화학식 1로 표시된다.The organic compound of the present invention is a structure in which two indene moieties containing one or more heteroatoms such as N, O, and S are fused to each other to form a basic skeleton, and various substituents are bonded to each other. Is displayed.

유기 전계 발광 소자의 인광 발광층에서 호스트는 삼중항 에너지 갭이 도펀트보다 높아야 한다. 즉, 도펀트로부터 효과적으로 인광 발광을 제공하기 위해서는 호스트의 가장 낮은 여기 상태의 에너지가 도펀트의 가장 낮은 방출 상태의 에너지보다 높아야 한다. 상기 화학식 1로 표시되는 화합물은 넓은 일중항 에너지 준위와 높은 삼중항 에너지 준위를 가지는 인덴 모이어티에 특정의 치환기가 도입되어 있기 때문에 호스트로 사용될 경우 도펀트보다 높은 에너지 준위를 나타낼 수 있다.In the phosphorescent layer of the organic EL device, the host should have a triplet energy gap higher than that of the dopant. That is, in order to effectively provide phosphorescence from the dopant, the energy of the lowest excited state of the host must be higher than the energy of the lowest emission state of the dopant. The compound represented by Formula 1 may exhibit a higher energy level than the dopant when used as a host because a specific substituent is introduced into the indene moiety having a wide singlet energy level and a high triplet energy level.

또한 본 발명의 화학식 1로 표시되는 화합물은 시아노기가 치환된 C6~C60의 아릴기 또는 시아노기가 치환된 핵원자수 5 내지 60의 헤테로아릴기를 적어도 1개 이상 포함함에 따라 분자 전체가 바이폴라(bipolar) 특성을 가지기 때문에 호스르토 사용될 경우 발광층에서의 정공과 전자의 결합력을 높일 수 있다. In addition, the compound represented by the formula (1) of the present invention includes at least one or more C 6 ~ C 60 aryl group substituted with a cyano group or at least one heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group Since it has a bipolar characteristic, when the host is used, the binding force between the holes and the electrons in the emission layer may be increased.

한편 본 발명의 화학식 1로 표시되는 화합물은 발광층에서 생성된 엑시톤이 인접하는 전자수송층 또는 정공수송층으로 확산되는 것을 방지하여, 발광에 기여하는 엑시톤의 수를 증가시키기 때문에 발광보조층에 사용될 경우 발광 효율뿐만 아니라 유기 전계 발광 소자의 수명도 향상시킬 수 있다.Meanwhile, the compound represented by Chemical Formula 1 of the present invention prevents the excitons generated in the light emitting layer from diffusing to the adjacent electron transport layer or the hole transport layer, thereby increasing the number of excitons that contribute to the light emission, so that the light emission efficiency when used in the light emitting auxiliary layer In addition, the life of the organic EL device can be improved.

또한 본 발명의 화학식 1로 표시되는 화합물은 다양한 치환체, 특히 아릴기 및/또는 헤테로아릴기가 도입되어 화합물의 분자량이 유의적으로 증대됨으로써 높은 유리전이온도를 나타내기 때문에 종래의 유기물층 재료(예를 들어, CBP)보다 우수한 열적 안정성을 가질 수 있다. 또 상기 화학식 1로 표시되는 화합물은 유기물층의 결정화 억제에도 효과가 있다.In addition, the compound represented by the general formula (1) of the present invention exhibits a high glass transition temperature by introducing various substituents, especially aryl groups and / or heteroaryl groups, thereby significantly increasing the molecular weight of the compound. , CBP) can have better thermal stability. In addition, the compound represented by the formula (1) is effective in suppressing the crystallization of the organic material layer.

따라서 본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층에 적용할 경우 유기 전계 발광 소자의 성능 및 수명 특성이 크게 향상될 수 있다. 또한 이러한 유기 전계 발광 소자 수명 향상은 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.Therefore, when the compound represented by Chemical Formula 1 of the present invention is applied to the organic material layer of the organic EL device, the performance and lifespan characteristics of the organic EL device may be greatly improved. In addition, the lifespan of the organic EL device may maximize the performance of the full color OLED panel.

이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물로 구체화 될 수 있다.Such a compound represented by Formula 1 of the present invention may be embodied as a compound represented by the following formula (1a to 1f).

[화학식 1a][Formula 1a]

Figure PCTKR2015000699-appb-I000003
Figure PCTKR2015000699-appb-I000003

[화학식 1b][Formula 1b]

Figure PCTKR2015000699-appb-I000004
Figure PCTKR2015000699-appb-I000004

[화학식 1c][Formula 1c]

Figure PCTKR2015000699-appb-I000005
Figure PCTKR2015000699-appb-I000005

[화학식 1d][Formula 1d]

Figure PCTKR2015000699-appb-I000006
Figure PCTKR2015000699-appb-I000006

[화학식 1e][Formula 1e]

Figure PCTKR2015000699-appb-I000007
Figure PCTKR2015000699-appb-I000007

[화학식 1f][Formula 1f]

Figure PCTKR2015000699-appb-I000008
Figure PCTKR2015000699-appb-I000008

상기 화학식 1a 내지 1f에서, X1 내지 X4 및 Y1 내지 Y8은 상기 화학식 1에서 정의한 바와 같다.In Chemical Formulas 1a to 1f, X 1 to X 4 and Y 1 to Y 8 are the same as defined in Chemical Formula 1.

상기 화학식 1a 내지 1f에서, Y1 내지 Y4는 N 또는 C(R1)인데, 모두 C(R1)인 것이 바람직하며, Y5 내지 Y8은 N 또는 C(R3)인데, 모두 C(R3)인 것이 바람직하다. 이때 복수의 R1 및 R3는 서로 동일하거나 상이하다.In Formulas 1a to 1f, Y 1 to Y 4 are N or C (R 1 ), all of which are preferably C (R 1 ), and Y 5 to Y 8 are N or C (R 3 ), all of which are C that the (R 3) are preferred. In this case, a plurality of R 1 and R 3 are the same or different from each other.

본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 B-1 내지 B-30으로 표시되는 화합물로 더욱 구체화 될 수 있으나, 이에 한정되는 것은 아니다.The compound represented by Chemical Formula 1 of the present invention may be further embodied by the compounds represented by the following Chemical Formulas B-1 to B-30, but is not limited thereto.

Figure PCTKR2015000699-appb-I000009
Figure PCTKR2015000699-appb-I000009

상기 화학식 B-1 내지 B-30에서, Ar1 및 R1 내지 R3는 상기 화학식 1에서 정의한 바와 같다. 이때, 복수의 R1은 서로 동일하거나 상이하고, 복수의 R2는 서로 동일하거나 상이하며, 복수의 R3는 서로 동일하거나 상이하다.In Formulas B-1 to B-30, Ar 1 and R 1 to R 3 are the same as defined in Formula 1. At this time, a plurality of R 1 is the same or different from each other, a plurality of R 2 is the same or different from each other, a plurality of R 3 is the same or different from each other.

한편 본 발명의 화학식 1로 표시되는 화합물에서, R1 내지 R3 및 Ar1 내지 Ar5는 각각 독립적으로, 수소, 중수소, 할로겐기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C1~C40의 포스핀기, C1~C40의 포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는데,Meanwhile, in the compound represented by Chemical Formula 1, R 1 to R 3 and Ar 1 to Ar 5 are each independently hydrogen, deuterium, a halogen group, a nitro group, an amino group, an alkyl group of C 1 to C 40 , and C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to the 60 heteroaryl group, C 1 to C 40 alkyloxy group, C 6 to C 60 aryloxy group, C 1 to C 40 alkylsilyl group, C 6 to C 60 arylsilyl group, C 1 to C 40 groups of an alkyl boron, an aryl boronic of C 6 ~ C 60, C 1 ~ C 40 phosphine group, C 1 ~ C 40 phosphine oxide group, and a C 6 ~ are selected from the group consisting of an aryl amine of the C 60 of the ,

상기 R1 내지 R3는 각각 독립적으로, 수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하며,R 1 to R 3 are each independently hydrogen, halogen, cyano group, C 1 ~ C 40 alkyl group, C 6 ~ C 60 aryl group, nuclear atoms 5 to 60 heteroaryl group and C 6 ~ C It is preferably selected from the group consisting of 60 arylamine groups,

상기 Ar1 내지 Ar5는 각각 독립적으로 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴아민기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되는 것이 바람직하다.Ar 1 to Ar 5 are each independently composed of a C 6 ~ C 60 aryl group, a heteroaryl group of 5 to 60 nuclear atoms, a C 6 ~ C 60 arylamine group and a C 6 ~ C 60 arylsilyl group It is preferably selected from the group.

또한 상기 R1 내지 R3 및 Ar1 내지 Ar5 중 적어도 하나는 시아노기가 치환된 C6~C60의 아릴기 또는 시아노기가 치환된 핵원자수 5 내지 60의 헤테로아릴기인데, 그 중에서도 Ar1이 시아노기가 치환된 C6~C60의 아릴기 또는 시아노기가 치환된 핵원자수 5 내지 60의 헤테로아릴기인 것이 바람직하다.In addition, at least one of R 1 to R 3 and Ar 1 to Ar 5 is a C 6 ~ C 60 aryl group substituted with a cyano group or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group, It is preferable that Ar 1 is a C 6 to C 60 aryl group substituted with a cyano group or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group.

구체적으로, 상기 R1 내지 R3 및 Ar1 내지 Ar5는 각각 독립적으로 수소 또는 하기 S1 내지 S204로 이루어진 치환기에서 선택되거나, 선택된 치환기에 1개 이상의 시아노기가 포함된(결합된) 치환기일 수 있다.Specifically, R 1 to R 3 and Ar 1 to Ar 5 may each independently be selected from hydrogen or a substituent consisting of S1 to S204, or a substituent including one or more cyano groups in the selected substituent (bonded) have.

Figure PCTKR2015000699-appb-I000010
Figure PCTKR2015000699-appb-I000010

Figure PCTKR2015000699-appb-I000011
Figure PCTKR2015000699-appb-I000011

Figure PCTKR2015000699-appb-I000012
Figure PCTKR2015000699-appb-I000012

Figure PCTKR2015000699-appb-I000013
Figure PCTKR2015000699-appb-I000013

이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 합성예를 참조하여 다양하게 합성할 수 있다.The compound represented by the formula (1) of the present invention can be synthesized in various ways with reference to the following synthesis examples.

2. 유기 전계 발광 소자2. Organic electroluminescent device

본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.The present invention provides an organic electroluminescent device comprising a compound represented by the formula (1).

구체적으로, 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 1종 이상 포함하는 유기 전계 발광 소자를 제공한다.Specifically, the present invention includes an anode, a cathode and at least one organic material layer interposed between the anode and the cathode, at least one of the organic material layer comprises an organic electric field comprising at least one compound represented by the formula (1) Provided is a light emitting device.

상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있다. 바람직하게는, 상기 화학식 1로 표시되는 화합물은 발광층 물질로서 유기 전계 발광 소자에 포함될 수 있다. 이 경우 유기 전계 발광 소자는 발광효율, 휘도, 전력효율, 열적 안정성 및 소자 수명이 향상될 수 있다.The organic material layer including the compound represented by Chemical Formula 1 may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer. Preferably, the compound represented by Formula 1 may be included in the organic electroluminescent device as a light emitting layer material. In this case, the organic EL device may improve luminous efficiency, brightness, power efficiency, thermal stability, and device life.

특히 본 발명의 화학식 1로 표시되는 화합물은 발광층의 인광 호스트, 형광 호스트 또는 도펀트 재료인 것이 바람직하며, 발광층의 인광 호스트 재료인 것이 더욱 바람직하다.In particular, the compound represented by Formula 1 of the present invention is preferably a phosphorescent host, a fluorescent host or a dopant material of the light emitting layer, and more preferably a phosphorescent host material of the light emitting layer.

이러한 본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 것일 수 있다. 상기 전자수송층 위에는 전자주입층이 삽입될 수도 있다. 상기 전극과 유기물층 계면에는 절연층 또는 접착층이 삽입될 수도 있다.The structure of the organic EL device of the present invention is not particularly limited, but a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and a cathode may be sequentially stacked. An electron injection layer may be inserted on the electron transport layer. An insulating layer or an adhesive layer may be inserted between the electrode and the organic material layer interface.

본 발명의 유기 전계 발광 소자에서 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 진공증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에 한정되지는 않는다.In the organic electroluminescent device of the present invention, the organic material layer including the compound represented by Chemical Formula 1 may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.

본 발명의 유기 전계 발광 소자는 유기물층 중 1층 이상을 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는 당 업계에 알려져 있는 재료 및 방법을 이용하여 유기물층 및 전극을 형성함으로써 제조될 수 있다.The organic electroluminescent device of the present invention may be manufactured by forming an organic material layer and an electrode using materials and methods known in the art, except that at least one layer of the organic material layer is formed to include the compound represented by Chemical Formula 1. have.

예컨대, 기판으로는 실리콘 웨이퍼, 석영 또는 유리판, 금속판, 플라스틱 필름 등이 사용될 수 있다.For example, a silicon wafer, a quartz or glass plate, a metal plate, a plastic film, or the like may be used as the substrate.

양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자; 또는 카본블랙 등이 사용될 수 있으나, 이들에 한정되는 것은 아니다.The anode material may be a metal such as vanadium, chromium, copper, zinc, gold or an alloy thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black may be used, but is not limited thereto.

음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 사용될 수 있으나, 이들에 한정되는 것은 아니다.The negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; A multilayer structure material such as LiF / Al or LiO 2 / Al may be used, but is not limited thereto.

이 외에 정공주입층, 정공수송층, 전자주입층 및 전자수송층으로 사용되는 물질은 당 업계에 알려진 통상의 물질이라면 특별히 한정되지 않는다.In addition, the material used as the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer is not particularly limited as long as it is a conventional material known in the art.

이하, 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples. However, the following examples are merely to illustrate the present invention and the present invention is not limited by the following examples.

[준비예 1] PC-1의 합성Preparation Example 1 Synthesis of PC-1

<단계 1> 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성<Step 1> Synthesis of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole

Figure PCTKR2015000699-appb-I000014
Figure PCTKR2015000699-appb-I000014

질소 기류 하에서 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd(dppf)Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22.32 g, 수율 72%)을 얻었다.5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3) under nitrogen stream , 2-dioxaborolane) (48.58 g, 0.191 mol), Pd (dppf) Cl 2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) were mixed and 130 ° C Stir at 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 10: 1 (v / v)), and purified by 5- (4,4,5,5-tetramethyl). -1,3,2-dioxaborolan-2-yl) -1H-indole (22.32 g, yield 72%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.95 (s, 1H), 8.21 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.95 (s, 1H), 8.21 ( s, 1 H)

<단계 2> 5-(2-nitrophenyl)-1H-indole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -1H-indole

Figure PCTKR2015000699-appb-I000015
Figure PCTKR2015000699-appb-I000015

질소 기류 하에서 1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol), 상기 <단계 1>에서 얻은 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22 g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) 및 THF/H2O(400 ml/200 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4 (4.36 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1H-indole (11.32 g, 수율 63%)을 얻었다.1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol) under nitrogen stream, 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) obtained in <Step 1> above -1H-indole (22 g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) and THF / H 2 O (400 ml / 200 ml) were mixed and then Pd (PPh 3 ) 4 (4.36 g) at 40 ° C. , 5 mol%) was added and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the organic layer obtained was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to give 5- (2-nitrophenyl) -1H-indole (11.32 g, 63% yield).

1H-NMR: δ 6.47 (d, 1H), 7.25 (d, 1H), 7.44 (d, 1H), 7.53 (d, 1H), 7.65 (t, 1H), 7.86 (t, 1H), 7.95 (s, 1H), 8.00 (d, 1H), 8.09 (t, 1H), 8.20 (s, 1H) 1 H-NMR: δ 6.47 (d, 1H), 7.25 (d, 1H), 7.44 (d, 1H), 7.53 (d, 1H), 7.65 (t, 1H), 7.86 (t, 1H), 7.95 ( s, 1H), 8.00 (d, 1H), 8.09 (t, 1H), 8.20 (s, 1H)

<단계 3> 5-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000016
Figure PCTKR2015000699-appb-I000016

질소 기류 하에서 상기 <단계 2>에서 얻은 5-(2-nitrophenyl)-1H-indole (11 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K2CO3 (6.38 g, 46.17 mmol), Na2SO4 (6.56 g, 46.17 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1-phenyl-1H-indole (10.30 g, 수율 71%)을 얻었다.5- (2-nitrophenyl) -1H-indole (11 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K 2 obtained in the above <Step 2> under a nitrogen stream CO 3 (6.38 g, 46.17 mmol), Na 2 SO 4 (6.56 g, 46.17 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C. for 12 h. After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer, which was freed of water, and then purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to give 5- (2-nitrophenyl) -1-phenyl-1H-indole (10.30 g, yield). 71%).

1H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.45 (m, 3H), 7.55 (m, 4H), 7.63 (t, 1H), 7.84 (t, 1H), 7.93 (s, 1H), 8.01 (d, 1H), 8.11 (t, 1H) 1 H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.45 (m, 3H), 7.55 (m, 4H), 7.63 (t, 1H), 7.84 (t, 1H), 7.93 ( s, 1H), 8.01 (d, 1H), 8.11 (t, 1H)

<단계 4> PC-1의 합성<Step 4> Synthesis of PC-1

Figure PCTKR2015000699-appb-I000017
Figure PCTKR2015000699-appb-I000017

질소 기류 하에서 상기 <단계 3>에서 얻은 5-(2-nitrophenyl)-1-phenyl-1H-indole (5 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) 및 1,2-dichlorobenzene (50 ml)를 혼합하고 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane:MC=3:1 (v/v))로 정제하여 PC-1 (2.38 g, 수율 53%)을 얻었다.5- (2-nitrophenyl) -1-phenyl-1H-indole (5 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) and 1,2-dichlorobenzene (50 ml) obtained in <Step 3> under a nitrogen stream. ) Was mixed and stirred for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed and extracted with dichloromethane. Water was removed with MgSO 4, and the resulting organic layer was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain PC-1 (2.38 g, yield 53%).

1H-NMR: δ 6.99 (d, 1H), 7.12 (t, 1H), 7.27 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.50 (d, 1H), 7.60 (m, 5H), 7.85 (d, 1H), 8.02 (d, 1H), 10.59 (s, 1H) 1 H-NMR: δ 6.99 (d, 1H), 7.12 (t, 1H), 7.27 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.50 (d, 1H), 7.60 ( m, 5H), 7.85 (d, 1H), 8.02 (d, 1H), 10.59 (s, 1H)

[준비예 2] PC-2의 합성Preparation Example 2 Synthesis of PC-2

Figure PCTKR2015000699-appb-I000018
Figure PCTKR2015000699-appb-I000018

5-(2-nitrophenyl)-1-phenyl-1H-indole, triphenylphosphine 및 1,2-dichlorobenzene을 사용하여 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 PC-2을 얻었다.PC-2 was obtained by the same procedure as in <Step 4> of Preparation Example 1 using 5- (2-nitrophenyl) -1-phenyl-1H-indole, triphenylphosphine and 1,2-dichlorobenzene.

1H-NMR: δ 6.98 (d, 1H), 7.13 (t, 1H), 7.26 (t, 1H), 7.33 (d, 1H), 7.42 (t, 1H), 7.51 (s, 1H), 7.61 (m, 5H), 7.84 (d, 1H), 8.03 (s, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.98 (d, 1H), 7.13 (t, 1H), 7.26 (t, 1H), 7.33 (d, 1H), 7.42 (t, 1H), 7.51 (s, 1H), 7.61 ( m, 5H), 7.84 (d, 1H), 8.03 (s, 1H), 10.58 (s, 1H)

[준비예 3] PC-3의 합성Preparation Example 3 Synthesis of PC-3

<단계 1> 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성Step 1 Synthesis of 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole

Figure PCTKR2015000699-appb-I000019
Figure PCTKR2015000699-appb-I000019

5-bromo-1H-indole 대신 6-bromo-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.Except for using 6-bromo-1H-indole instead of 5-bromo-1H-indole by following the same procedure as in <Step 1> of Preparation Example 1 6- (4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl) -1H-indole was obtained.

1H-NMR: δ 1.25 (s, 12H), 6.52 (d, 1H), 7.16 (d, 1H), 7.21 (d, 1H), 7.49 (d, 1H), 7.53 (s, 1H), 8.15 (s, 1H) 1 H-NMR: δ 1.25 (s, 12H), 6.52 (d, 1H), 7.16 (d, 1H), 7.21 (d, 1H), 7.49 (d, 1H), 7.53 (s, 1H), 8.15 ( s, 1 H)

<단계 2> 6-(2-nitrophenyl)-1H-indole의 합성Step 2 Synthesis of 6- (2-nitrophenyl) -1H-indole

Figure PCTKR2015000699-appb-I000020
Figure PCTKR2015000699-appb-I000020

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 <단계 1>에서 얻은 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 2>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1H-indole을 얻었다.6- (4,4,5,5-tetramethyl- obtained in <Step 1> instead of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole Except for using 1,3,2-dioxaborolan-2-yl) -1H-indole, 6- (2-nitrophenyl) -1H-indole was prepared in the same manner as in <Step 2> of Preparation Example 1. Got it.

1H-NMR: δ 6.57 (d, 1H), 7.07 (d, 1H), 7.24 (d, 1H), 7.35 (s, 1H), 7.43 (t, 1H), 7.50 (d, 1H), 7.58 (t, 1H), 7.66 (d, 1H), 7.78 (d, 1H), 8.19 (s, 1H) 1 H-NMR: δ 6.57 (d, 1H), 7.07 (d, 1H), 7.24 (d, 1H), 7.35 (s, 1H), 7.43 (t, 1H), 7.50 (d, 1H), 7.58 ( t, 1H), 7.66 (d, 1H), 7.78 (d, 1H), 8.19 (s, 1H)

<단계 3> 6-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000021
Figure PCTKR2015000699-appb-I000021

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 6-(2-nitrophenyl)-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.The same procedure as in <Step 3> of Preparation Example 1 was performed except that 6- (2-nitrophenyl) -1H-indole obtained in <Step 2> was used instead of 5- (2-nitrophenyl) -1H-indole. 6- (2-nitrophenyl) -1-phenyl-1H-indole was obtained.

1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.35 (s, 1H), 7.43 (d, 1H), 7.51 (m, 3H), 7.56 (m, 2H), 7.62 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H) 1 H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.35 (s, 1H), 7.43 (d, 1H), 7.51 (m, 3H), 7.56 ( m, 2H), 7.62 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H)

<단계 4> PC-3의 합성<Step 4> Synthesis of PC-3

Figure PCTKR2015000699-appb-I000022
Figure PCTKR2015000699-appb-I000022

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 6-(2-nitrophenyl)-1-phenyl-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 PC-3을 얻었다.Preparation Example 1, except that 6- (2-nitrophenyl) -1-phenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-3 was obtained by performing the same procedure as in <Step 4>.

1H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.23 (t, 1H), 7.42 (d, 1H), 7.50 (m, 3H), 7.57 (m, 2H), 7.63 (m, 2H), 7.86 (d, 1H), 8.03 (d, 1H), 9.81 (s, 1H) 1 H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.23 (t, 1H), 7.42 (d, 1H), 7.50 (m, 3H), 7.57 (m, 2H), 7.63 ( m, 2H), 7.86 (d, 1H), 8.03 (d, 1H), 9.81 (s, 1H)

[준비예 4] PC-4의 합성Preparation Example 4 Synthesis of PC-4

Figure PCTKR2015000699-appb-I000023
Figure PCTKR2015000699-appb-I000023

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 6-(2-nitrophenyl)-1-phenyl-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 PC-4을 얻었다.The same procedure as in <Step 4> of Preparation Example 1, except that 6- (2-nitrophenyl) -1-phenyl-1H-indole is used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole Was performed to obtain PC-4.

1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.43 (s, 1H), 7.51 (m, 3H), 7.58 (m, 2H), 7.64 (m, 2H), 7.85 (d, 1H), 8.02 (s, 1H), 9.82 (s, 1H) 1 H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.43 (s, 1H), 7.51 (m, 3H), 7.58 (m, 2H), 7.64 ( m, 2H), 7.85 (d, 1H), 8.02 (s, 1H), 9.82 (s, 1H)

[준비예 5] PC-5의 합성Preparation Example 5 Synthesis of PC-5

<단계 1> 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성<Step 1> Synthesis of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole

Figure PCTKR2015000699-appb-I000024
Figure PCTKR2015000699-appb-I000024

5-bromo-1H-indole 대신 4-bromo-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.Except for using 4-bromo-1H-indole instead of 5-bromo-1H-indole by performing the same process as in <Step 1> of Preparation Example 1 4- (4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl) -1H-indole was obtained.

1H NMR: δ 1.26 (s, 12H), 6.43 (d, 1H), 7.26 (t, 1H), 7.48 (d, 1H), 7.74 (d, 1H), 7.85 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 1.26 (s, 12H), 6.43 (d, 1H), 7.26 (t, 1H), 7.48 (d, 1H), 7.74 (d, 1H), 7.85 (d, 1H), 8.23 (s , 1H)

<단계 2> 4-(2-nitrophenyl)-1H-indole의 합성<Step 2> Synthesis of 4- (2-nitrophenyl) -1H-indole

Figure PCTKR2015000699-appb-I000025
Figure PCTKR2015000699-appb-I000025

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 <단계 1>에서 얻은 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-nitrophenyl)-1H-indole을 얻었다.4- (4,4,5,5-tetramethyl- obtained in <Step 1> instead of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole Except for using 1,3,2-dioxaborolan-2-yl) -1H-indole, 4- (2-nitrophenyl) -1H-indole was prepared in the same manner as in <Step 2> of Preparation Example 1 above. Got it.

1H NMR: δ 6.45 (d, 1H), 7.27 (t, 1H), 7.50 (d, 1H), 7.66 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 7.99 (d, 1H), 8.04 (d, 1H), 8.24 (s, 1H) 1 H NMR: δ 6.45 (d, 1H), 7.27 (t, 1H), 7.50 (d, 1H), 7.66 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 7.99 (d , 1H), 8.04 (d, 1H), 8.24 (s, 1H)

<단계 3> 4-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 4- (2-nitrophenyl) -1-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000026
Figure PCTKR2015000699-appb-I000026

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 4-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 4-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 4- (2-nitrophenyl) -1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1H-indole, the same procedure as in <Step 3> of Preparation Example 1 was performed. 4- (2-nitrophenyl) -1-phenyl-1H-indole was obtained.

1H NMR: δ 6.47 (d, 1H), 7.28 (t, 1H), 7.47 (m, 2H), 7.52 (m, 2H), 7.60 (m, 2H), 7.67 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 8.00 (d, 1H), 8.06 (d, 1H) 1 H NMR: δ 6.47 (d, 1H), 7.28 (t, 1H), 7.47 (m, 2H), 7.52 (m, 2H), 7.60 (m, 2H), 7.67 (t, 1H), 7.75 (d , 1H), 7.89 (m, 2H), 8.00 (d, 1H), 8.06 (d, 1H)

<단계 4> PC-5의 합성Step 4 Synthesis of PC-5

Figure PCTKR2015000699-appb-I000027
Figure PCTKR2015000699-appb-I000027

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 4-(2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 PC-5을 얻었다.Except for using 4- (2-nitrophenyl) -1-phenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole < PC-5 was obtained by following the same procedure as in Step 4>.

1H NMR: δ 6.49 (d, 1H), 7.29 (t, 1H), 7.46 (m, 2H), 7.54 (m, 2H), 7.61 (d, 1H), 7.69 (t, 1H), 7.74 (d, 1H), 7.88 (m, 2H), 8.01 (d, 1H), 8.04 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 6.49 (d, 1H), 7.29 (t, 1H), 7.46 (m, 2H), 7.54 (m, 2H), 7.61 (d, 1H), 7.69 (t, 1H), 7.74 (d , 1H), 7.88 (m, 2H), 8.01 (d, 1H), 8.04 (d, 1H), 8.23 (s, 1H)

[준비예 6] PC-6의 합성Preparation Example 6 Synthesis of PC-6

<단계 1> 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole의 합성<Step 1> Synthesis of 7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole

Figure PCTKR2015000699-appb-I000028
Figure PCTKR2015000699-appb-I000028

5-bromo-1H-indole 대신 7-bromo-1H-indole를 사용하는 것을 제외하고는 준비예 1의 <단계 1>과 동일한 과정을 수행하여 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.Except for using 7-bromo-1H-indole instead of 5-bromo-1H-indole by following the same procedure as in <Step 1> of Preparation Example 1 7- (4,4,5,5-tetramethyl-1 , 3,2-dioxaborolan-2-yl) -1H-indole was obtained.

1H NMR: δ 1.25 (s, 12H), 6.43 (d, 1H), 7.25 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.71 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 1.25 (s, 12H), 6.43 (d, 1H), 7.25 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.71 (d, 1H), 8.22 (s , 1H)

<단계 2> 7-(2-nitrophenyl)-1H-indole의 합성Step 2 Synthesis of 7- (2-nitrophenyl) -1H-indole

Figure PCTKR2015000699-appb-I000029
Figure PCTKR2015000699-appb-I000029

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 <단계 1>에서 얻은 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 7-(2-nitrophenyl)-1H-indole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole instead of 7- (4,4,5,5-tetramethyl- obtained in <Step 1> Except for using 1,3,2-dioxaborolan-2-yl) -1H-indole to obtain 7- (2-nitrophenyl) -1H-indole in the same manner as in <Step 2> of Preparation Example 1 .

1H NMR: δ 6.42 (d, 1H), 7.24 (d, 1H), 7.43 (t, 1H), 7.55 (d, 1H), 7.70 (m, 2H), 7.88 (t, 1H), 8.01 (d, 1H), 8.11 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 6.42 (d, 1H), 7.24 (d, 1H), 7.43 (t, 1H), 7.55 (d, 1H), 7.70 (m, 2H), 7.88 (t, 1H), 8.01 (d , 1H), 8.11 (d, 1H), 8.23 (s, 1H)

<단계 3> 7-(2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 3> Synthesis of 7- (2-nitrophenyl) -1-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000030
Figure PCTKR2015000699-appb-I000030

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 7-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.The same procedure as in <Step 3> of Preparation Example 1 was performed except that 7- (2-nitrophenyl) -1H-indole obtained in <Step 2> was used instead of 5- (2-nitrophenyl) -1H-indole. To obtain 7- (2-nitrophenyl) -1-phenyl-1H-indole.

1H NMR: δ 6.43 (d, 1H), 7.26 (d, 1H), 7.44 (m, 3H), 7.56 (m, 4H), 7.71 (m, 2H), 7.89 (t, 1H), 8.02 (d, 1H), 8.10 (d, 1H) 1 H NMR: δ 6.43 (d, 1H), 7.26 (d, 1H), 7.44 (m, 3H), 7.56 (m, 4H), 7.71 (m, 2H), 7.89 (t, 1H), 8.02 (d , 1H), 8.10 (d, 1H)

<단계 4> PC-6의 합성<Step 4> Synthesis of PC-6

Figure PCTKR2015000699-appb-I000031
Figure PCTKR2015000699-appb-I000031

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 7-(2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 PC-6을 얻었다.Except for using 7- (2-nitrophenyl) -1-phenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole < PC-6 was obtained by following the same procedure as in Step 4>.

1H NMR: δ 6.45 (d, 1H), 7.24 (d, 1H), 7.45 (m, 3H), 7.57 (m, 3H), 7.63 (d, 1H), 7.70 (d, 1H), 7.88 (t, 1H), 8.00 (d, 1H), 8.09 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 6.45 (d, 1H), 7.24 (d, 1H), 7.45 (m, 3H), 7.57 (m, 3H), 7.63 (d, 1H), 7.70 (d, 1H), 7.88 (t , 1H), 8.00 (d, 1H), 8.09 (d, 1H), 8.22 (s, 1H)

[준비예 7] PC-7의 합성Preparation Example 7 Synthesis of PC-7

<단계 1> 5-(5-bromo-2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 5- (5-bromo-2-nitrophenyl) -1H-indole

Figure PCTKR2015000699-appb-I000032
Figure PCTKR2015000699-appb-I000032

1-bromo-2-nitrobenzene 대신 2,4-dibromo-1-nitrobenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1H-indole을 얻었다.Except for using 2,4-dibromo-1-nitrobenzene instead of 1-bromo-2-nitrobenzene, the process was carried out in the same manner as in <Step 2> of Preparation Example 1 to 5- (5-bromo-2-nitrophenyl)- 1H-indole was obtained.

1H NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.45 (d, 1H), 7.55 (d, 1H), 7.64 (d, 1H), 7.85 (d, 1H), 7.96 (s, 1H), 8.13 (s, 1H), 8.21 (s, 1H) 1 H NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.45 (d, 1H), 7.55 (d, 1H), 7.64 (d, 1H), 7.85 (d, 1H), 7.96 (s , 1H), 8.13 (s, 1H), 8.21 (s, 1H)

<단계 2> 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 2> Synthesis of 5- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000033
Figure PCTKR2015000699-appb-I000033

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 1>에서 얻은 5-(5-bromo-2-nitrophenyl)-1H-indole 을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 5- (5-bromo-2-nitrophenyl) -1H-indole obtained in <Step 1> instead of 5- (2-nitrophenyl) -1H-indole and <Step 3> of Preparation Example 1 The same procedure was followed to obtain 5- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole.

1H NMR: δ 6.44 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 4H), 7.65 (d, 1H), 7.86 (d, 1H), 7.95 (s, 1H), 8.11 (s, 1H) 1 H NMR: δ 6.44 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 4H), 7.65 (d, 1H), 7.86 (d, 1H), 7.95 (s , 1H), 8.11 (s, 1H)

<단계 3> PC-7의 합성<Step 3> Synthesis of PC-7

Figure PCTKR2015000699-appb-I000034
Figure PCTKR2015000699-appb-I000034

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 2>에서 얻은 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 PC-7을 얻었다.Preparation except using 5- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-7 was obtained by performing the same procedure as in <Step 4> of Example 1.

1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.38 (m, 2H), 7.45 (d, 1H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 (d, 1H), 7.85 (d, 1H), 8.10 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.38 (m, 2H), 7.45 (d, 1H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 ( d, 1H), 7.85 (d, 1H), 8.10 (s, 1H), 8.23 (s, 1H)

[준비예 8] PC-8의 합성Preparation Example 8 Synthesis of PC-8

<단계 1> 6-(5-bromo-2-nitrophenyl)-1H-indole의 합성<Step 1> Synthesis of 6- (5-bromo-2-nitrophenyl) -1H-indole

Figure PCTKR2015000699-appb-I000035
Figure PCTKR2015000699-appb-I000035

1-bromo-2-nitrobenzene과 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 2,4-dibromo-1-nitrobenzene과 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1H-indole을 얻었다.2,4-dibromo-1-nitrobenzene and 6- instead of 1-bromo-2-nitrobenzene and 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole Except for using (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole, the same procedure as in <Step 2> of Preparation Example 1 was performed. (5-bromo-2-nitrophenyl) -1H-indole was obtained.

1H NMR: δ 6.51 (d, 1H), 7.31 (d, 1H), 7.50 (d, 1H), 7.60 (d, 1H), 7.69 (d, 1H), 7.90 (d, 1H), 8.01 (s, 1H), 8.14 (s, 1H), 8.25 (s, 1H) 1 H NMR: δ 6.51 (d, 1H), 7.31 (d, 1H), 7.50 (d, 1H), 7.60 (d, 1H), 7.69 (d, 1H), 7.90 (d, 1H), 8.01 (s , 1H), 8.14 (s, 1H), 8.25 (s, 1H)

<단계 2> 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole의 합성<Step 2> Synthesis of 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000036
Figure PCTKR2015000699-appb-I000036

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 1>에서 얻은 6-(5-bromo-2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 6- (5-bromo-2-nitrophenyl) -1H-indole obtained in <Step 1> instead of 5- (2-nitrophenyl) -1H-indole and <Step 3> of Preparation Example 1 The same procedure was followed to obtain 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole.

1H NMR: δ 6.49 (d, 1H), 7.30 (d, 1H), 7.51 (m, 3H), 7.61 (m, 4H), 7.70 (d, 1H), 7.91 (d, 1H), 8.00 (s, 1H), 8.16 (s, 1H) 1 H NMR: δ 6.49 (d, 1H), 7.30 (d, 1H), 7.51 (m, 3H), 7.61 (m, 4H), 7.70 (d, 1H), 7.91 (d, 1H), 8.00 (s , 1H), 8.16 (s, 1H)

<단계 3> PC-8의 합성<Step 3> Synthesis of PC-8

Figure PCTKR2015000699-appb-I000037
Figure PCTKR2015000699-appb-I000037

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 2>에서 얻은 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 PC-8을 얻었다.Preparation except for using 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-8 was obtained by performing the same procedure as in <Step 4> of Example 1.

1H-NMR: δ 6.47 (d, 1H), 7.28 (d, 1H), 7.40 (m, 2H), 7.47 (d, 1H), 7.53 (d, 1H), 7.59 (m, 3H), 7.66 (d, 1H), 7.87 (d, 1H), 8.12 (s, 1H), 8.25 (s, 1H) 1 H-NMR: δ 6.47 (d, 1H), 7.28 (d, 1H), 7.40 (m, 2H), 7.47 (d, 1H), 7.53 (d, 1H), 7.59 (m, 3H), 7.66 ( d, 1H), 7.87 (d, 1H), 8.12 (s, 1H), 8.25 (s, 1H)

[준비예 9] PC-9의 합성Preparation Example 9 Synthesis of PC-9

<단계 1> 5-bromo-2-phenyl-1H-indole의 합성<Step 1> Synthesis of 5-bromo-2-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000038
Figure PCTKR2015000699-appb-I000038

질소 기류 하에서 5-bromo-1H-indole (25 g, 0.13 mol), Iodobenzene (31.22 g, 0.15 mol), Pd(OAc)2 (1.43 g, 5 mol%), Triphenylphosphine (1.67 g, 5 mol%), KOAc (37.55 g, 0.38 mol) 및 H2O (300 ml)를 혼합하고 110℃에서 24시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-bromo-2-phenyl-1H-indole (16.66 g, 수율 48%)을 얻었다.5-bromo-1H-indole (25 g, 0.13 mol), Iodobenzene (31.22 g, 0.15 mol), Pd (OAc) 2 (1.43 g, 5 mol%), Triphenylphosphine (1.67 g, 5 mol%) under nitrogen stream , KOAc (37.55 g, 0.38 mol) and H 2 O (300 ml) were mixed and stirred at 110 ° C. for 24 h. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 5-bromo-2-phenyl-1H-indole ( 16.66 g, yield 48%).

1H-NMR: δ 6.89 (dd, 1H), 7.20 (dd, 1H), 7.34 (m, 1H), 7.36 (d, 1H), 7.47 (t, 2H), 7.71 (d, 1H), 7.86 (dd, 2H), 11.74 (s, 1H) 1 H-NMR: δ 6.89 (dd, 1H), 7.20 (dd, 1H), 7.34 (m, 1H), 7.36 (d, 1H), 7.47 (t, 2H), 7.71 (d, 1H), 7.86 ( dd, 2H), 11.74 (s, 1H)

<단계 2> 5-(2-nitrophenyl)-2-phenyl-1H-indole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -2-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000039
Figure PCTKR2015000699-appb-I000039

질소 기류 하에서 2-nitrophenylboronic acid (11.04 g, 66.14 mmol), 상기 <단계 1>에서 얻은, 5-bromo-2-phenyl-1H-indole (15 g, 55.12 mmol), NaOH (6.61 g, 165.36 mmol) 및 THF/H2O(200 ml/100 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(3.18 g, 5 mol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 5:1 (v/v))로 정제하여 5-(2-nitrophenyl)-2-phenyl-1H-indole (10.74 g, 수율 62%)을 얻었다.2-nitrophenylboronic acid (11.04 g, 66.14 mmol) under nitrogen stream, 5-bromo-2-phenyl-1H-indole (15 g, 55.12 mmol), NaOH (6.61 g, 165.36 mmol) obtained in <Step 1> above And THF / H 2 O (200 ml / 100 ml) were mixed, Pd (PPh 3 ) 4 (3.18 g, 5 mol) was added at 40 ° C., and the mixture was stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 5: 1 (v / v)) to give 5- (2-nitrophenyl) -2-phenyl-1H-indole (10.74 g, yield 62%). Got.

1H-NMR: δ 6.88 (dd, 1H), 7.21 (d, 1H), 7.32 (m, 1H), 7.34 (d, 1H), 7.46 (m, 3H), 7.64 (m, 2H), 7.77 (d, 2H), 8.02 (d, 2H), 11.73 (s, 1H) 1 H-NMR: δ 6.88 (dd, 1H), 7.21 (d, 1H), 7.32 (m, 1H), 7.34 (d, 1H), 7.46 (m, 3H), 7.64 (m, 2H), 7.77 ( d, 2H), 8.02 (d, 2H), 11.73 (s, 1H)

<단계 3> 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1,2-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000040
Figure PCTKR2015000699-appb-I000040

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 5-(2-nitrophenyl)-2-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 얻었다.Except for using 5- (2-nitrophenyl) -2-phenyl-1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1H-indole and <Step 3> of Preparation Example 1 The same procedure was followed to obtain 5- (2-nitrophenyl) -1,2-diphenyl-1H-indole.

GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)

<단계 4> PC-9의 합성Step 4 Synthesis of PC-9

Figure PCTKR2015000699-appb-I000041
Figure PCTKR2015000699-appb-I000041

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 PC-9을 얻었다.Preparation Example except for using 5- (2-nitrophenyl) -1,2-diphenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-9 was obtained by performing the same procedure as in <Step 4> of 1.

GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (Theoretical value: 358.15 g / mol, Measured value: 358 g / mol)

[준비예 10] PC-10의 합성Preparation Example 10 Synthesis of PC-10

<단계 1> 6-chloro-2-phenyl-1H-indole의 합성<Step 1> Synthesis of 6-chloro-2-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000042
Figure PCTKR2015000699-appb-I000042

5-bromo-1H-indole과 Iodobenzene 대신 6-chloro-1H-indole과 bromobenzene을 사용하는 것을 제외하고는 상기 준비예 9의 <단계 1>과 동일한 과정을 수행하여 6-chloro-2-phenyl-1H-indole을 얻었다.Except for using 6-chloro-1H-indole and bromobenzene instead of 5-bromo-1H-indole and Iodobenzene to the same process as in <Step 1> of Preparation Example 9 6-chloro-2-phenyl-1H got -indole

1H-NMR: δ 6.92 (d, 1H), 7.02 (dd, 1H), 7.33 (t, 1H), 7.41 (s, 1H), 7.47 (t, 2H), 7.54 (d, 1H), 7.85 (d, 2H), 11.68 (s, 1H) 1 H-NMR: δ 6.92 (d, 1H), 7.02 (dd, 1H), 7.33 (t, 1H), 7.41 (s, 1H), 7.47 (t, 2H), 7.54 (d, 1H), 7.85 ( d, 2H), 11.68 (s, 1H)

<단계 2> 6-(2-nitrophenyl)-2-phenyl-1H-indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -2-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000043
Figure PCTKR2015000699-appb-I000043

5-bromo-2-phenyl-1H-indole 대신 상기 <단계 1>에서 얻은 6-chloro-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 9의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-2-phenyl-1H-indole을 얻었다.Except for using 6-chloro-2-phenyl-1H-indole obtained in <step 1> instead of 5-bromo-2-phenyl-1H-indole the same procedure as in <step 2> of Preparation Example 9 6- (2-nitrophenyl) -2-phenyl-1H-indole was obtained.

1H-NMR: δ 6.91 (d, 1H), 7.03 (d, 1H), 7.31 (t, 1H), 7.42 (s, 1H), 7.48 (m, 3H), 7.53 (d, 1H), 7.76 (m, 3H), 8.01 (d, 2H), 11.66 (s, 1H) 1 H-NMR: δ 6.91 (d, 1H), 7.03 (d, 1H), 7.31 (t, 1H), 7.42 (s, 1H), 7.48 (m, 3H), 7.53 (d, 1H), 7.76 ( m, 3H), 8.01 (d, 2H), 11.66 (s, 1H)

<단계 3> 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole의 합성Step 3 Synthesis of 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000044
Figure PCTKR2015000699-appb-I000044

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 6-(2-nitrophenyl)-2-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 얻었다.Except for using 6- (2-nitrophenyl) -2-phenyl-1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1H-indole and <Step 3> of Preparation Example 1 The same procedure was followed to obtain 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole.

GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)

<단계 4> 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole의 합성Step 4 Synthesis of 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000045
Figure PCTKR2015000699-appb-I000045

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 2>에서 얻은 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 PC-10을 얻었다.Preparation Example except for using 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-10 was obtained in the same manner as in <Step 4> of 1.

GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (Theoretical value: 358.15 g / mol, Measured value: 358 g / mol)

[준비예 11] PC-11의 합성Preparation Example 11 Synthesis of PC-11

<단계 1> 6-chloro-3-phenyl-1H-indole의 합성<Step 1> Synthesis of 6-chloro-3-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000046
Figure PCTKR2015000699-appb-I000046

질소 기류 하에서 6-chloro-1H-indole (25 g, 0.17 mol), bromobenzene (31.19 g, 0.20 mol), Pd(OAc)2 (1.86 g, 5 mol), Triphenylphosphine (2.17 g, 5 mol%), K2CO3 (68.64 g, 0.50 mol) 및 1,4-dioxane (300 ml)를 혼합하고 130℃에서 18시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 6-chloro-3-phenyl-1H-indole (24.5 g, 수율 65%)을 얻었다.6-chloro-1H-indole (25 g, 0.17 mol), bromobenzene (31.19 g, 0.20 mol), Pd (OAc) 2 (1.86 g, 5 mol), Triphenylphosphine (2.17 g, 5 mol%), under nitrogen stream K 2 CO 3 (68.64 g, 0.50 mol) and 1,4-dioxane (300 ml) were mixed and stirred at 130 ° C. for 18 hours. After completion of the reaction, the mixture was extracted with ethyl acetate, followed by removing water with MgSO 4 , and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 6-chloro-3-phenyl-1H-indole ( 24.5 g, yield 65%) was obtained.

1H-NMR: δ 7.10 (dd, 1H), 7.25 (m, 1H), 7.43 (t, 2H), 7.49 (d, 1H), 7.67 (dd, 2H), 7.73 (d, 1H), 7.85 (d, 1H), 11.49 (s, 1H) 1 H-NMR: δ 7.10 (dd, 1H), 7.25 (m, 1H), 7.43 (t, 2H), 7.49 (d, 1H), 7.67 (dd, 2H), 7.73 (d, 1H), 7.85 ( d, 1 H), 11.49 (s, 1 H)

<단계 2> 6-(2-nitrophenyl)-3-phenyl-1H-indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -3-phenyl-1H-indole

Figure PCTKR2015000699-appb-I000047
Figure PCTKR2015000699-appb-I000047

5-bromo-2-phenyl-1H-indole 대신 상기 <단계 1>에서 얻은 6-chloro-3-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 9의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-3-phenyl-1H-indole을 얻었다.Except for using 6-chloro-3-phenyl-1H-indole obtained in <step 1> instead of 5-bromo-2-phenyl-1H-indole the same procedure as in <step 2> of Preparation Example 9 6- (2-nitrophenyl) -3-phenyl-1H-indole was obtained.

1H-NMR: δ 7.11 (d, 1H), 7.26 (m, 1H), 7.44 (t, 2H), 7.48 (m, 2H), 7.55 (m, 3H), 7.61 (d, 1H), 7.73 (d, 1H), 8.00 (d, 2H), 11.48 (s, 1H) 1 H-NMR: δ 7.11 (d, 1H), 7.26 (m, 1H), 7.44 (t, 2H), 7.48 (m, 2H), 7.55 (m, 3H), 7.61 (d, 1H), 7.73 ( d, 1H), 8.00 (d, 2H), 11.48 (s, 1H)

<단계 3> 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000048
Figure PCTKR2015000699-appb-I000048

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 6-(2-nitrophenyl)-3-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole을 얻었다.Except for using 6- (2-nitrophenyl) -3-phenyl-1H-indole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1H-indole and <Step 3> of Preparation Example 1 The same procedure was followed to obtain 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole.

GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)

<단계 4> 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole의 합성Step 4 Synthesis of 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000049
Figure PCTKR2015000699-appb-I000049

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 PC-11을 얻었다.Preparation Example except for using 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-11 was obtained by performing the same procedure as in <Step 4> of 1.

GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (Theoretical value: 358.15 g / mol, Measured value: 358 g / mol)

[준비예 12] PC-12의 합성Preparation Example 12 Synthesis of PC-12

<단계 1> 5-bromo-2,3-diphenyl-1H-indole의 합성<Step 1> Synthesis of 5-bromo-2,3-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000050
Figure PCTKR2015000699-appb-I000050

6-chloro-1H-indole 대신 5-bromo-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 11의 <단계 1>과 동일한 과정을 수행하여 5-bromo-2,3-diphenyl-1H-indole을 얻었다.Except for using 5-bromo-2-phenyl-1H-indole instead of 6-chloro-1H-indole by performing the same process as in <Step 1> of Preparation Example 11 5-bromo-2,3-diphenyl -1 H-indole was obtained.

1H-NMR: δ 7.23 (d, 1H), 7.31 (t, 2H), 7.43 (m, 6H), 7.67 (d, 1H), 7.71 (d, 1H), 7.84 (d, 2H), 11.34 (s, 1H) 1 H-NMR: δ 7.23 (d, 1H), 7.31 (t, 2H), 7.43 (m, 6H), 7.67 (d, 1H), 7.71 (d, 1H), 7.84 (d, 2H), 11.34 ( s, 1 H)

<단계 2> 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -2,3-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000051
Figure PCTKR2015000699-appb-I000051

5-bromo-2-phenyl-1H-indole 대신 상기 <단계 1>에서 얻은 5-bromo-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 9의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 얻었다.Except for using 5-bromo-2,3-diphenyl-1H-indole obtained in <step 1> instead of 5-bromo-2-phenyl-1H-indole is the same as <step 2> of Preparation Example 9 The procedure was followed to obtain 5- (2-nitrophenyl) -2,3-diphenyl-1H-indole.

GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)

<단계 3> 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole

Figure PCTKR2015000699-appb-I000052
Figure PCTKR2015000699-appb-I000052

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 얻었다.<Step 3 of Preparation Example 1, except that 5- (2-nitrophenyl) -2,3-diphenyl-1H-indole obtained in <Step 2> was used instead of 5- (2-nitrophenyl) -1H-indole. > The same process as in to obtain 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole.

GC-Mass (이론치: 466.17 g/mol, 측정치: 466 g/mol)GC-Mass (Theoretical value: 466.17 g / mol, Measured value: 466 g / mol)

<단계 4> PC-12의 합성Step 4 Synthesis of PC-12

Figure PCTKR2015000699-appb-I000053
Figure PCTKR2015000699-appb-I000053

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 PC-12을 얻었다.Except for using 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-12 was obtained by performing the same procedure as <Step 4> of Preparation Example 1.

GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (Theoretical value: 434.18 g / mol, Measured value: 434 g / mol)

[준비예 13] PC-13의 합성Preparation Example 13 Synthesis of PC-13

<단계 1> 6-chloro-2,3-diphenyl-1H-indole의 합성<Step 1> Synthesis of 6-chloro-2,3-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000054
Figure PCTKR2015000699-appb-I000054

6-chloro-1H-indole 대신 6-chloro-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 11의 <단계 1>과 동일한 과정을 수행하여 6-chloro-2,3-diphenyl-1H-indole을 얻었다.Except for using 6-chloro-2-phenyl-1H-indole instead of 6-chloro-1H-indole to perform the same process as in <Step 1> of Preparation Example 11 6-chloro-2,3-diphenyl -1 H-indole was obtained.

1H-NMR: δ 7.18 (d, 1H), 7.29 (t, 2H), 7.50 (m, 6H), 7.62 (d, 1H), 7.75 (d, 1H), 7.89 (d, 2H), 11.35 (s, 1H) 1 H-NMR: δ 7.18 (d, 1H), 7.29 (t, 2H), 7.50 (m, 6H), 7.62 (d, 1H), 7.75 (d, 1H), 7.89 (d, 2H), 11.35 ( s, 1 H)

<단계 2> 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole

Figure PCTKR2015000699-appb-I000055
Figure PCTKR2015000699-appb-I000055

5-bromo-2-phenyl-1H-indole 대신 상기 <단계 1>에서 얻은 6-chloro-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 9의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 얻었다.Except for using 6-chloro-2,3-diphenyl-1H-indole obtained in <step 1> instead of 5-bromo-2-phenyl-1H-indole is the same as <step 2> of Preparation Example 9 The procedure was followed to obtain 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole.

GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (Theoretical value: 390.14 g / mol, Measured value: 390 g / mol)

<단계 3> 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole

Figure PCTKR2015000699-appb-I000056
Figure PCTKR2015000699-appb-I000056

5-(2-nitrophenyl)-1H-indole 대신 상기 <단계 2>에서 얻은 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 얻었다.<Step 3 of Preparation Example 1, except that 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole obtained in <Step 2> was used instead of 5- (2-nitrophenyl) -1H-indole. 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole was obtained by following the same procedure as>.

GC-Mass (이론치: 466.17 g/mol, 측정치: 466 g/mol)GC-Mass (Theoretical value: 466.17 g / mol, Measured value: 466 g / mol)

<단계 4> PC-13의 합성<Step 4> Synthesis of PC-13

Figure PCTKR2015000699-appb-I000057
Figure PCTKR2015000699-appb-I000057

5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 3>에서 얻은 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 PC-13을 얻었다.Except for using 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole PC-13 was obtained by performing the same procedure as <Step 4> of Preparation Example 1.

GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (Theoretical value: 434.18 g / mol, Measured value: 434 g / mol)

[준비예 14] IC-1의 합성Preparation 14 Synthesis of IC-1

<단계 1> 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole의 합성<Step 1> Synthesis of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole

Figure PCTKR2015000699-appb-I000058
Figure PCTKR2015000699-appb-I000058

질소 기류 하에서 5-bromo-1H-indazole (25.22 g, 0.128 mol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd(dppf)Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole (22.49 g, 수율 72%)을 얻었다.5-bromo-1H-indazole (25.22 g, 0.128 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3) under nitrogen stream , 2-dioxaborolane) (48.58 g, 0.191 mol), Pd (dppf) Cl 2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) were mixed and 130 ° C Stir at 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate and then dried with MgSO 4 , purified by column chromatography (Hexane: EA = 10: 1 (v / v)), and purified by 5- (4,4,5,5-tetramethyl). -1,3,2-dioxaborolan-2-yl) -1H-indazole (22.49 g, yield 72%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 7.60 (d, 1H), 8.15 (m, 2H), 8.34 (d, 1H), 12.34 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.60 (d, 1H), 8.15 (m, 2H), 8.34 (d, 1H), 12.34 (s, 1H)

<단계 2> 5-(2-nitrophenyl)-1H-indazole의 합성<Step 2> Synthesis of 5- (2-nitrophenyl) -1H-indazole

Figure PCTKR2015000699-appb-I000059
Figure PCTKR2015000699-appb-I000059

질소 기류 하에서 1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol), 상기 <단계 1>에서 얻은 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole (22.09 g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) 및 THF/H2O(400 ml/200 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(4.36 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1H-indazole (13.64 g, 수율 63%)을 얻었다.1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol) under nitrogen stream, 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) obtained in <Step 1> above -1H-indazole (22.09 g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) and THF / H 2 O (400 ml / 200 ml) were mixed and then Pd (PPh 3 ) 4 (4.36 g) at 40 ° C. , 5 mol%) was added and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 5- (2-nitrophenyl) -1H-indazole (13.64 g, 63% yield).

1H-NMR: δ 7.64 (m, 2H), 7.90 (m, 1H), 8.05 (m, 3H), 8.21 (s, 1H), 8.38(d, 1H), 12.24(s, 1H) 1 H-NMR: δ 7.64 (m, 2H), 7.90 (m, 1H), 8.05 (m, 3H), 8.21 (s, 1H), 8.38 (d, 1H), 12.24 (s, 1H)

<단계 3> 5-(2-nitrophenyl)-1-phenyl-1H-indazole의 합성<Step 3> Synthesis of 5- (2-nitrophenyl) -1-phenyl-1H-indazole

Figure PCTKR2015000699-appb-I000060
Figure PCTKR2015000699-appb-I000060

질소 기류 하에서 상기 <단계 2>에서 얻은 5-(2-nitrophenyl)-1H-indazole (11.04 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K2CO3 (6.38 g, 46.17 mmol), Na2SO4 (6.56 g, 46.17 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1-phenyl-1H-indazole (10.34 g, 수율 71%)을 얻었다.5- (2-nitrophenyl) -1H-indazole (11.04 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K 2 obtained in the above <Step 2> under a nitrogen stream CO 3 (6.38 g, 46.17 mmol), Na 2 SO 4 (6.56 g, 46.17 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C. for 12 h. After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer, which was then freed from water, and purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to give 5- (2-nitrophenyl) -1-phenyl-1H-indazole (10.34 g, yield 71%).

1H-NMR: δ 7.48 (t, 1H), 7.62 (m, 6H), 7.90 (m, 1H), 8.05 (m, 3H), 8.37 (m, 2H) 1 H-NMR: δ 7.48 (t, 1H), 7.62 (m, 6H), 7.90 (m, 1H), 8.05 (m, 3H), 8.37 (m, 2H)

<단계 4> IC-1의 합성Step 4 Synthesis of IC-1

Figure PCTKR2015000699-appb-I000061
Figure PCTKR2015000699-appb-I000061

질소 기류 하에서 상기 <단계 3>에서 얻은 5-(2-nitrophenyl)-1-phenyl-1H-indazole (5.01 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) 및 1,2-dichlorobenzene (50 ml)를 혼합하고 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane:MC=3:1 (v/v))로 정제하여 IC-1 (2.39 g, 수율 53%)을 얻었다.5- (2-nitrophenyl) -1-phenyl-1H-indazole (5.01 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) and 1,2-dichlorobenzene (50 ml) obtained in <Step 3> under a nitrogen stream. ) Was mixed and stirred for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed and extracted with dichloromethane. The obtained organic layer was removed with MgSO 4, and purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain IC-1 (2.39 g, yield 53%).

1H-NMR: δ 7.29 (t, 1H), 7.45 (m, 3H), 7.60 (m, 5H), 8.12 (d, 1H), 8.33 (d, 2H), 10.09 (s, 1H) 1 H-NMR: δ 7.29 (t, 1H), 7.45 (m, 3H), 7.60 (m, 5H), 8.12 (d, 1H), 8.33 (d, 2H), 10.09 (s, 1H)

[준비예 15] IC-2의 합성Preparation Example 15 Synthesis of IC-2

<단계 1> 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole의 합성<Step 1> Synthesis of 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole

Figure PCTKR2015000699-appb-I000062
Figure PCTKR2015000699-appb-I000062

5-bromo-1H-indazole 대신 6-bromo-1H-indazole를 사용하는 것을 제외하고는 상기 준비예 14의 <단계 1>과 동일한 과정을 수행하여 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole을 얻었다.Except for using 6-bromo-1H-indazole instead of 5-bromo-1H-indazole, 6- (4,4,5,5-tetramethyl- was carried out in the same manner as in <Step 1> of Preparation Example 14 above. 1,3,2-dioxaborolan-2-yl) -1H-indazole was obtained.

1H-NMR: δ 1.25 (s, 12H), 7.48 (d, 1H), 7.89 (m, 2H), 8.21 (s, 1H), 12.15 (s, 1H) 1 H-NMR: δ 1.25 (s, 12H), 7.48 (d, 1H), 7.89 (m, 2H), 8.21 (s, 1H), 12.15 (s, 1H)

<단계 2> 6-(2-nitrophenyl)-1H-indazole의 합성Step 2 Synthesis of 6- (2-nitrophenyl) -1H-indazole

Figure PCTKR2015000699-appb-I000063
Figure PCTKR2015000699-appb-I000063

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 대신 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole를 사용하는 것을 제외하고는 상기 준비예 14의 <단계 2>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1H-indazole을 얻었다.5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole instead of 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan A 6- (2-nitrophenyl) -1H-indazole was obtained in the same manner as in <Step 2> of Preparation Example 14, except that 2-yl) -1H-indazole was used.

1H-NMR: δ 7.49 (d, 1H), 7.67 (t, 1H), 7.85 (s, 1H), 7.94 (m, 2H), 8.03 (m, 2H), 8.20 (s, 1H), 12.2 (s, 1H) 1 H-NMR: δ 7.49 (d, 1H), 7.67 (t, 1H), 7.85 (s, 1H), 7.94 (m, 2H), 8.03 (m, 2H), 8.20 (s, 1H), 12.2 ( s, 1 H)

<단계 3> 6-(2-nitrophenyl)-1-phenyl-1H-indazole의 합성<Step 3> Synthesis of 6- (2-nitrophenyl) -1-phenyl-1H-indazole

Figure PCTKR2015000699-appb-I000064
Figure PCTKR2015000699-appb-I000064

5-(2-nitrophenyl)-1H-indazole 대신 6-(2-nitrophenyl)-1H-indazole를 사용하는 것을 제외하고는 상기 준비예 14의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Except for using 6- (2-nitrophenyl) -1H-indazole instead of 5- (2-nitrophenyl) -1H-indazole, 6- (2- nitrophenyl) -1-phenyl-1H-indole was obtained.

1H-NMR: δ 7.47 (m, 2H), 7.62 (m, 5H), 7.83 (s, 1H), 7.95 (m, 2H), 8.02 (m, 2H), 8.39 (s, 1H) 1 H-NMR: δ 7.47 (m, 2H), 7.62 (m, 5H), 7.83 (s, 1H), 7.95 (m, 2H), 8.02 (m, 2H), 8.39 (s, 1H)

<단계 4> IC-2의 합성Step 4 Synthesis of IC-2

Figure PCTKR2015000699-appb-I000065
Figure PCTKR2015000699-appb-I000065

5-(2-nitrophenyl)-1-phenyl-1H-indazole 대신 6-(2-nitrophenyl)-1-phenyl-1H-indazole를 사용하는 것을 제외하고는 상기 준비예 14의 <단계 4>과 동일한 과정을 수행하여 IC-2을 얻었다.The same process as in <Step 4> of Preparation Example 14, except that 6- (2-nitrophenyl) -1-phenyl-1H-indazole is used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indazole Was carried out to obtain IC-2.

1H-NMR: δ 7.27 (m, 2H), 7.45 (t, 1H), 7.54 (m, 6H), 7.95 (d, 1H), 8.12 (d, 1H), 8.37 (s, 1H), 10.53 (s, 1H) 1 H-NMR: δ 7.27 (m, 2H), 7.45 (t, 1H), 7.54 (m, 6H), 7.95 (d, 1H), 8.12 (d, 1H), 8.37 (s, 1H), 10.53 ( s, 1 H)

[준비예 16] IC-3의 합성Preparation Example 16 Synthesis of IC-3

Figure PCTKR2015000699-appb-I000066
Figure PCTKR2015000699-appb-I000066

5-(2-nitrophenyl)-1-phenyl-1H-indazole 대신 6-(2-nitrophenyl)-1-phenyl-1H-indazole를 사용하는 것을 제외하고는 상기 준비예 14의 <단계 4>과 동일한 과정을 수행하여 IC-3을 얻었다.The same process as in <Step 4> of Preparation Example 14, except that 6- (2-nitrophenyl) -1-phenyl-1H-indazole is used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indazole Was carried out to obtain IC-3.

1H-NMR: δ 7.29 (t, 1H), 7.45 (t, 1H), 7.50 (m, 1H), 7.58 (m, 6H), 7.88 (s, 1H), 8.11 (d, 1H), 8.33 (s, 1H), 10.64 (s, 1H) 1 H-NMR: δ 7.29 (t, 1H), 7.45 (t, 1H), 7.50 (m, 1H), 7.58 (m, 6H), 7.88 (s, 1H), 8.11 (d, 1H), 8.33 ( s, 1H), 10.64 (s, 1H)

[준비예 17] IC-4의 합성Preparation 17 Synthesis of IC-4

<단계 1> 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole의 합성<Step 1> Synthesis of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole

Figure PCTKR2015000699-appb-I000067
Figure PCTKR2015000699-appb-I000067

5-bromo-1H-indazole 대신 4-bromo-1H-indazole를 사용하는 것을 제외하고는 상기 준비예 14의 <단계 1>과 동일한 과정을 수행하여 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole을 얻었다.Except for using 4-bromo-1H-indazole instead of 5-bromo-1H-indazole, 4- (4,4,5,5-tetramethyl- was carried out in the same manner as in <Step 1> of Preparation Example 14 above. 1,3,2-dioxaborolan-2-yl) -1H-indazole was obtained.

1H NMR: δ 1.26 (s, 12H), 7.43 (d, 1H), 7.66 (t, 1H), 8.28 (m, 2H), 12.23 (s, 1H) 1 H NMR: δ 1.26 (s, 12H), 7.43 (d, 1H), 7.66 (t, 1H), 8.28 (m, 2H), 12.23 (s, 1H)

<단계 2> 4-(2-nitrophenyl)-1H-indazole의 합성<Step 2> Synthesis of 4- (2-nitrophenyl) -1H-indazole

Figure PCTKR2015000699-appb-I000068
Figure PCTKR2015000699-appb-I000068

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 대신 상기 <단계 1>에서 얻은 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole을 사용하는 것을 제외하고는 상기 준비예 14의 <단계 2>와 동일한 과정을 수행하여 4-(2-nitrophenyl)-1H-indazole을 얻었다.4- (4,4,5,5-tetramethyl- obtained in <Step 1> instead of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole Except for using 1,3,2-dioxaborolan-2-yl) -1H-indazole, 4- (2-nitrophenyl) -1H-indazole was prepared in the same manner as in <Step 2> of Preparation Example 14 above. Got it.

1H NMR: δ 7.49 (d, 1H), 7.68 (m, 2H), 7.90 (t, 1H), 8.01 (m, 2H), 8.24 (m, 2H), 12.39 (s, 1H) 1 H NMR: δ 7.49 (d, 1H), 7.68 (m, 2H), 7.90 (t, 1H), 8.01 (m, 2H), 8.24 (m, 2H), 12.39 (s, 1H)

<단계 3> 4-(2-nitrophenyl)-1-phenyl-1H-indazole의 합성<Step 3> Synthesis of 4- (2-nitrophenyl) -1-phenyl-1H-indazole

Figure PCTKR2015000699-appb-I000069
Figure PCTKR2015000699-appb-I000069

5-(2-nitrophenyl)-1H-indazole 대신 상기 <단계 2>에서 얻은 4-(2-nitrophenyl)-1H-indazole을 사용하는 것을 제외하고는 준비예 14의 <단계 3>과 동일한 과정을 수행하여 4-(2-nitrophenyl)-1-phenyl-1H-indazole을 얻었다.Except for using 4- (2-nitrophenyl) -1H-indazole obtained in <Step 2> instead of 5- (2-nitrophenyl) -1H-indazole, the same procedure as in <Step 3> of Preparation Example 14 was performed. 4- (2-nitrophenyl) -1-phenyl-1H-indazole was obtained.

1H NMR: δ 7.47 (m, 2H), 7.64 (m, 6H), 7.90 (t, 1H), 8.00 (m, 2H), 8.31 (m, 2H) 1 H NMR: δ 7.47 (m, 2H), 7.64 (m, 6H), 7.90 (t, 1H), 8.00 (m, 2H), 8.31 (m, 2H)

<단계 4> IC-4의 합성Step 4 Synthesis of IC-4

Figure PCTKR2015000699-appb-I000070
Figure PCTKR2015000699-appb-I000070

5-(2-nitrophenyl)-1-phenyl-1H-indazole 대신 상기 <단계 3>에서 얻은 4-(2-nitrophenyl)-1-phenyl-1H-indazole을 사용하는 것을 제외하고는 준비예 14의 <단계 4>와 동일한 과정을 수행하여 IC-4을 얻었다.Except for using 4- (2-nitrophenyl) -1-phenyl-1H-indazole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indazole IC-4 was obtained by the same procedure as in step 4>.

1H NMR: δ 7.30 (t, 1H), 7.52 (m, 7H), 8.08 (m, 2H), 8.35 (m, 2H), 10.21 (s, 1H) 1 H NMR: δ 7.30 (t, 1H), 7.52 (m, 7H), 8.08 (m, 2H), 8.35 (m, 2H), 10.21 (s, 1H)

[준비예 18] IC-5의 합성Preparation Example 18 Synthesis of IC-5

<단계 1> 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole의 합성<Step 1> Synthesis of 7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole

Figure PCTKR2015000699-appb-I000071
Figure PCTKR2015000699-appb-I000071

5-bromo-1H-indazole 대신 7-bromo-1H-indazole를 사용하는 것을 제외하고는 준비예 14의 <단계 1>과 동일한 과정을 수행하여 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole을 얻었다.Except for using 7-bromo-1H-indazole instead of 5-bromo-1H-indazole, the procedure of 7- (4,4,5,5-tetramethyl-1 was carried out in the same manner as in <Step 1> of Preparation Example 14 , 3,2-dioxaborolan-2-yl) -1H-indazole was obtained.

1H NMR: δ 1.25 (s, 12H), 7.44 (t, 1H), 7.62 (d, 1H), 7.95 (d, 1H), 8.36 (s, 1H), 12.51 (s, 1H) 1 H NMR: δ 1.25 (s, 12H), 7.44 (t, 1H), 7.62 (d, 1H), 7.95 (d, 1H), 8.36 (s, 1H), 12.51 (s, 1H)

<단계 2> 7-(2-nitrophenyl)-1H-indazole의 합성Step 2 Synthesis of 7- (2-nitrophenyl) -1H-indazole

Figure PCTKR2015000699-appb-I000072
Figure PCTKR2015000699-appb-I000072

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 대신 상기 <단계 1>에서 얻은 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole을 사용하는 것을 제외하고는 준비예 14의 <단계 2>와 동일한 과정을 수행하여 7-(2-nitrophenyl)-1H-indazole을 얻었다.Instead of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indazole, 7- (4,4,5,5-tetramethyl- obtained in <Step 1> above Except that 1,3,2-dioxaborolan-2-yl) -1H-indazole was used, 7- (2-nitrophenyl) -1H-indazole was obtained in the same manner as in <Step 2> of Preparation Example 14. .

1H NMR: δ 7.62 (m, 3H), 7.95 (m, 4H), 8.22 (s, 1H), 12.47 (s, 1H) 1 H NMR: δ 7.62 (m, 3H), 7.95 (m, 4H), 8.22 (s, 1H), 12.47 (s, 1H)

<단계 3> 7-(2-nitrophenyl)-1-phenyl-1H-indazole의 합성<Step 3> Synthesis of 7- (2-nitrophenyl) -1-phenyl-1H-indazole

Figure PCTKR2015000699-appb-I000073
Figure PCTKR2015000699-appb-I000073

5-(2-nitrophenyl)-1H-indazole 대신 상기 <단계 2>에서 얻은 7-(2-nitrophenyl)-1H-indazole을 사용하는 것을 제외하고는 준비예 14의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-1-phenyl-1H-indazole을 얻었다.The same procedure as in <Step 3> of Preparation Example 14 was performed except that 7- (2-nitrophenyl) -1H-indazole obtained in <Step 2> was used instead of 5- (2-nitrophenyl) -1H-indazole. 7- (2-nitrophenyl) -1-phenyl-1H-indazole was obtained.

1H NMR: δ 7.58 (m, 8H), 7.89 (m, 2H), 8.02 (m, 2H), 8.39 (s, 1H) 1 H NMR: δ 7.58 (m, 8H), 7.89 (m, 2H), 8.02 (m, 2H), 8.39 (s, 1H)

<단계 4> IC-5의 합성Step 4 Synthesis of IC-5

Figure PCTKR2015000699-appb-I000074
Figure PCTKR2015000699-appb-I000074

5-(2-nitrophenyl)-1-phenyl-1H-indazole 대신 상기 <단계 3>에서 얻은 7-(2-nitrophenyl)-1-phenyl-1H-indazole을 사용하는 것을 제외하고는 준비예 14의 <단계 4>와 동일한 과정을 수행하여 IC-5을 얻었다.Except for using 7- (2-nitrophenyl) -1-phenyl-1H-indazole obtained in <Step 3> instead of 5- (2-nitrophenyl) -1-phenyl-1H-indazole IC-5 was obtained by the same procedure as in step 4>.

1H NMR: δ 7.28 (t, 1H), 7.55 (m, 7H), 7.92 (d, 2H), 8.14 (d, 1H), 8.33 (s, 1H), 10.70 (s, 1H) 1 H NMR: δ 7.28 (t, 1H), 7.55 (m, 7H), 7.92 (d, 2H), 8.14 (d, 1H), 8.33 (s, 1H), 10.70 (s, 1H)

[준비예 19] BOC-1 & BOC-2의 합성Preparation Example 19 Synthesis of BOC-1 & BOC-2

<단계 1> N-(2,4-dibromophenyl)benzamide의 합성Step 1 Synthesis of N- (2,4-dibromophenyl) benzamide

Figure PCTKR2015000699-appb-I000075
Figure PCTKR2015000699-appb-I000075

반응기에 2,4-dibromoaniline (250.9 g, 1.0 mol)을 투입하고, methylene chloride (1,000 ml)를 가한 후 교반하였다. 반응기에 benzoyl chloride (116 mL,1.0 mol), pyridine (161.8 mL, 2.0 mol)을 적가하고 상온에서 2시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 N-(2,4-dibromophenyl)benzamide (252.1 g, 수율 71%)를 얻었다.2,4-dibromoaniline (250.9 g, 1.0 mol) was added to the reactor, and methylene chloride (1,000 ml) was added thereto, followed by stirring. Benzoyl chloride (116 mL, 1.0 mol) and pyridine (161.8 mL, 2.0 mol) were added dropwise to the reactor, followed by stirring at room temperature for 2 hours. After completion of the reaction, the mixture was extracted with methylene chloride, followed by water removal with MgSO 4 , and purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain N- (2,4-dibromophenyl) benzamide (252.1 g, yield 71%).

1H-NMR: δ 7.52 (d, 1H), 7.59 (d, 1H), 7.63 (dd, 2H), 7.70 (t, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 9.15 (b, 1H) 1 H-NMR: δ 7.52 (d, 1H), 7.59 (d, 1H), 7.63 (dd, 2H), 7.70 (t, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 9.15 ( b, 1H)

<단계 2> 6-bromo-2-phenylbenzo[d]oxazole의 합성<Step 2> Synthesis of 6-bromo-2-phenylbenzo [d] oxazole

Figure PCTKR2015000699-appb-I000076
Figure PCTKR2015000699-appb-I000076

질소 기류 하에서 N-(2,4-dibromophenyl)benzamide (251.1 g, 710 mmol), K2CO3 (196.3 g, 1420 mmol) 및 DMSO (7100 ml)를 혼합하고 140℃에서 1.5시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 9:1 (v/v))로 정제하여 6-bromo-2-phenylbenzo[d]oxazole (147.9 g, 수율 76%)을 얻었다.N- (2,4-dibromophenyl) benzamide (251.1 g, 710 mmol), K 2 CO 3 (196.3 g, 1420 mmol) and DMSO (7100 ml) were mixed under nitrogen stream and stirred at 140 ° C. for 1.5 hours. After completion of the reaction, the mixture was extracted with ethyl acetate, followed by removing water with MgSO 4 , and purified by column chromatography (Hexane: EA = 9: 1 (v / v)) to obtain 6-bromo-2-phenylbenzo [d] oxazole ( 147.9 g, yield 76%).

1H-NMR: δ 7.41 (t, 1H) 7.43 (s, 1H), 7.51 (m, 3H), 7.60 (d, 1H), 8.05 (d, 2H) 1 H-NMR: δ 7.41 (t, 1H) 7.43 (s, 1H), 7.51 (m, 3H), 7.60 (d, 1H), 8.05 (d, 2H)

<단계 3> 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole의 합성<Step 3> Synthesis of 2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole

Figure PCTKR2015000699-appb-I000077
Figure PCTKR2015000699-appb-I000077

질소 기류 하에서 6-bromo-2-phenylbenzo[d]oxazole (147.9 g, 540.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd(dppf)Cl2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) 및 1,4-Dioxane (2800 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole (133.5 g, 수율 77%)을 얻었다.6-bromo-2-phenylbenzo [d] oxazole (147.9 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to 2-phenyl-6- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole (133.5 g, yield 77%) was obtained.

1H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H), 7.75 (s, 1H), 8.05 (d, 2H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H), 7.75 (s, 1H), 8.05 (d , 2H)

<단계 4> 6-(2-nitrophenyl)-2-phenylbenzo[d]oxazole의 합성Step 4 Synthesis of 6- (2-nitrophenyl) -2-phenylbenzo [d] oxazole

Figure PCTKR2015000699-appb-I000078
Figure PCTKR2015000699-appb-I000078

질소 기류 하에서 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole (133.5 g, 415.8 mmol), 1-bromo-2-nitrobenzene (92.4 g, 457.4 mmol), Pd(PPh3)4 (24.0 g, 20.8 mmol), K2CO3 (143.7 g, 1.04 mol), 1,4-dioxane/H2O (400 ml/100 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 6-(2-nitrophenyl)-2-phenylbenzo[d]oxazole (110.5 g, 수율 84%)을 얻었다.2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole (133.5 g, 415.8 mmol), 1-bromo-2 under nitrogen stream -nitrobenzene (92.4 g, 457.4 mmol), Pd (PPh 3 ) 4 (24.0 g, 20.8 mmol), K 2 CO 3 (143.7 g, 1.04 mol), 1,4-dioxane / H 2 O (400 ml / 100 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to give 6- (2-nitrophenyl) -2-phenylbenzo [d] oxazole (110.5 g, 84% yield). Got.

1H-NMR: δ 7.41-7.51 (m, 4H), 7.67-7.68 (m, 2H), 7.79 (d, 1H), 7.90 (dd, 1H), 8.00-8.05 (m, 4H) 1 H-NMR: δ 7.41-7.51 (m, 4H), 7.67-7.68 (m, 2H), 7.79 (d, 1H), 7.90 (dd, 1H), 8.00-8.05 (m, 4H)

<단계 5> BOC-1과 BOC-2의 합성Step 5 Synthesis of BOC-1 and BOC-2

Figure PCTKR2015000699-appb-I000079
Figure PCTKR2015000699-appb-I000079

질소 기류 하에서 6-(2-nitrophenyl)-2-phenylbenzo[d]oxazole (110.5 g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol), 1,2-dichlorobenzene 1500 ml를 넣은 후 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 목적 화합물인 BOC-1 (55.6g, 수율 56 %)과 BOC-2 (32.7g, 수율 33 %)를 획득하였다.Under nitrogen stream, 6- (2-nitrophenyl) -2-phenylbenzo [d] oxazole (110.5 g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol) and 1,2-dichlorobenzene 1500 ml were added thereto, followed by stirring for 12 hours. . After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer, and the residue was purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain BOC-1 (55.6g, 56%) and BOC-2 (32.7g, yield). 33%) was obtained.

BOC-1의 1H-NMR: δ 7.23-7.29 (m, 2H), 7.41-7.51 (m, 4H), 7.63 (d, 1H), 8.05-8.12 (m, 4H), 10.1 (b, 1H) 1 H-NMR of BOC-1: δ 7.23-7.29 (m, 2H), 7.41-7.51 (m, 4H), 7.63 (d, 1H), 8.05-8.12 (m, 4H), 10.1 (b, 1H)

BOC-2의 1H-NMR: δ 7.29 (dd, 1H), 7.40-7.55 (m, 7H), 8.05-8.12 (m, 3H), 10.1 (b, 1H) 1 H-NMR of BOC-2: δ 7.29 (dd, 1H), 7.40-7.55 (m, 7H), 8.05-8.12 (m, 3H), 10.1 (b, 1H)

[준비예 20] BOC-3의 합성Preparation Example 20 Synthesis of BOC-3

<단계 1> 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]oxazole의 합성Step 1 Synthesis of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] oxazole

Figure PCTKR2015000699-appb-I000080
Figure PCTKR2015000699-appb-I000080

질소 기류 하에서 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole (133.5 g, 415.8 mmol), 4-bromo-2-iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd(PPh3)4 (24.0 g, 20.8 mmol), K2CO3 (143.7 g, 1.04 mol), 1,4-dioxane/H2O (400 ml/100 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]oxazole (138 g, 수율 84%)을 얻었다.2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] oxazole (133.5 g, 415.8 mmol), 4-bromo-2 under nitrogen stream -iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd (PPh 3 ) 4 (24.0 g, 20.8 mmol), K 2 CO 3 (143.7 g, 1.04 mol), 1,4-dioxane / H 2 O ( 400 ml / 100 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] oxazole (138 g, Yield 84%).

1H-NMR: δ 7.41 (t, 1H) 7.48 (s, 1H), 7.51 (dd, 2H), 7.68 (d, 1H), 7.72 (s, 1H), 7.79 (d, 1H), 7.98 (d, 1H), 8.05 (d, 2H), 8.21 (d, 1H) 1 H-NMR: δ 7.41 (t, 1H) 7.48 (s, 1H), 7.51 (dd, 2H), 7.68 (d, 1H), 7.72 (s, 1H), 7.79 (d, 1H), 7.98 (d , 1H), 8.05 (d, 2H), 8.21 (d, 1H)

<단계 2> 7-bromo-2-phenyl-10H-oxazole[5,4-a]carbazole과 8-bromo-2-phenyl-5H-oxazole[4,5-b]carbazole의 합성<Step 2> Synthesis of 7-bromo-2-phenyl-10H-oxazole [5,4-a] carbazole with 8-bromo-2-phenyl-5H-oxazole [4,5-b] carbazole

Figure PCTKR2015000699-appb-I000081
Figure PCTKR2015000699-appb-I000081

질소 기류 하에서 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]oxazole (138g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol), 1,2-dichlorobenzene 1500 ml를 넣은 후 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 4:1 (v/v))로 정제하여 7-bromo-2-phenyl-10H-oxazole[5,4-a]carbazole (70.1g, 수율 53 %)와 8-bromo-2-phenyl-5H-oxazole[4,5-b]carbazole (41.0g, 수율 31 %)를 획득하였다.12 hours after adding 1500 ml of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] oxazole (138g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol) and 1,2-dichlorobenzene under nitrogen stream Was stirred. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: MC = 4: 1 (v / v)) to obtain 7-bromo-2-phenyl-10H-oxazole [5,4-a] carbazole (70.1 g, Yield 53%) and 8-bromo-2-phenyl-5H-oxazole [4,5-b] carbazole (41.0g, 31% yield).

7-bromo-2-phenyl-10H-oxazole[5,4-a]carbazole의 1H-NMR: δ 7.23 (d, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H) 1 H-NMR of 7-bromo-2-phenyl-10H-oxazole [5,4-a] carbazole: δ 7.23 (d, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 8.05 (m, 3H), 8.12 (d, 1H), 10.1 (b, 1H)

8-bromo-2-phenyl-5H-oxazole[4,5-b]carbazole의 1H-NMR: δ 7.40 (s, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 7.55 (s, 1H), 8.05 (m, 3H), 10.1 (b, 1H) 1 H-NMR of 8-bromo-2-phenyl-5H-oxazole [4,5-b] carbazole: δ 7.40 (s, 1H), 7.41 (t, 1H) 7.42 (d, 1H), 7.51 (dd, 2H), 7.52 (d, 1H), 7.55 (s, 1H), 8.05 (m, 3H), 10.1 (b, 1H)

<단계 3> 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole의 합성<Step 3> Synthesis of 2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole

Figure PCTKR2015000699-appb-I000082
Figure PCTKR2015000699-appb-I000082

질소 기류 하에서 7-bromo-2-phenyl-10H-oxazolo[5,4-a]carbazole (70.1 g, 193.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd(dppf)Cl2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) 및 1,4-Dioxane (1000 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 수율 81%)을 얻었다.7-bromo-2-phenyl-10H-oxazolo [5,4-a] carbazole (70.1 g, 193.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'- under nitrogen stream octamethyl-2,2'-bi (1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd (dppf) Cl 2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) and 1, 4-Dioxane (1000 ml) was mixed and stirred at 130 ° C. for 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to 2-phenyl-7- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (64.1 g, yield 81%) was obtained.

1H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H), 7.75 (s, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.44 (s, 1H), 7.51 (dd, 2H), 7.62 (d, 1H), 7.75 (s, 1H), 8.05 (d , 2H), 10.1 (b, 1H)

<단계 4> BOC-3의 합성Step 4 Synthesis of BOC-3

Figure PCTKR2015000699-appb-I000083
Figure PCTKR2015000699-appb-I000083

질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 156.2 mmol), iodobenzene (19 mL, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 m mol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 BOC-3 (48.4 g, 수율 86%)을 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (64.1 g, 156.2 mmol) under nitrogen stream ), iodobenzene (19 mL, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g, 390.5 m mol), 1,4-dioxane / H 2 O (160 ml / 40 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain BOC-3 (48.4 g, yield 86%).

1H-NMR: δ 7.23 (d, 1H) 7.41-7.52 (m, 8H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05-8.12 (m, 3H), 10.1 (b, 1H) 1 H-NMR: δ 7.23 (d, 1H) 7.41-7.52 (m, 8H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05-8.12 (m, 3H) , 10.1 (b, 1H)

[준비예 21] BOC-4의 합성Preparation 21 Synthesis of BOC-4

<단계 1> 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole의 합성<Step 1> Synthesis of 2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole

Figure PCTKR2015000699-appb-I000084
Figure PCTKR2015000699-appb-I000084

질소 기류 하에서 8-bromo-2-phenyl-5H-oxazolo[4,5-b]carbazole (41.0 g, 112.9 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd(dppf)Cl2 (13.1 g, 11.3 mmol), KOAc (31.9 g, 338.7 mmol) 및 1,4-Dioxane (700 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 수율 85%)을 얻었다.8-bromo-2-phenyl-5H-oxazolo [4,5-b] carbazole (41.0 g, 112.9 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'- under nitrogen stream octamethyl-2,2'-bi (1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd (dppf) Cl 2 (13.1 g, 11.3 mmol), KOAc (31.9 g, 338.7 mmol) and 1, 4-Dioxane (700 ml) was mixed and stirred at 130 ° C. for 12 h. After completion of the reaction, the mixture was extracted with ethyl acetate, followed by removal of water with MgSO 4 , and purification with column chromatography (Hexane: EA = 7: 1 (v / v)) to 2-phenyl-8- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (39.4 g, yield 85%) was obtained.

1H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.40 (s, 1H), 7.51 (m, 3H), 7.55 (s, 1H), 7.63 (d, 1H), 7.98 (s, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (d, 1H), 7.40 (s, 1H), 7.51 (m, 3H), 7.55 (s, 1H), 7.63 (d, 1H), 7.98 (s , 1H), 8.05 (d, 2H), 10.1 (b, 1H)

<단계 2> BOC-4의 합성Step 2 Synthesis of BOC-4

Figure PCTKR2015000699-appb-I000085
Figure PCTKR2015000699-appb-I000085

질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 96.0 mmol), iodobenzene (11.8 mL, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 BOC-4 (29.8 g, 수율 89%)를 얻었다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (39.4 g, 96.0 mmol) under nitrogen stream ), iodobenzene (11.8 mL, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g, 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the organic layer obtained was purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give BOC-4 (29.8 g, 89% yield).

1H-NMR: δ 7.40-7.55 (m, 10H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 7.40-7.55 (m, 10H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H)

[준비예 22] BOC-5의 합성Preparation 22 Synthesis of BOC-5

Figure PCTKR2015000699-appb-I000086
Figure PCTKR2015000699-appb-I000086

질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 156.2 mmol), 4-bromo-N,N-diphenylaniline (55.7 g, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 mmol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 BOC-5 (77.9 g, 수율 88%)를 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (64.1 g, 156.2 mmol) under nitrogen stream ), 4-bromo-N, N-diphenylaniline (55.7 g, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g, 390.5 mmol), 1,4-dioxane / H 2 O (160 ml / 40 ml) was mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain BOC-5 (77.9 g, yield 88%).

1H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20-7.23 (m, 5H), 7.40-7.54 (m, 5H), 7.69-7.87 (m, 3H), 8.05-8.12 (m, 3H), 10.1 (b, 1H) 1 H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20-7.23 (m, 5H), 7.40-7.54 (m, 5H), 7.69-7.87 (m, 3H), 8.05 -8.12 (m, 3H), 10.1 (b, 1H)

[준비예 23] BOC-6의 합성Preparation 23 Synthesis of BOC-6

Figure PCTKR2015000699-appb-I000087
Figure PCTKR2015000699-appb-I000087

질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 96.0 mmol), 4-bromo-N,N-diphenylaniline (34.2 g, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 BOC-6 (48.4 g, 수율 89%)을 얻었다. 2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (39.4 g, 96.0 mmol) under nitrogen stream ), 4-bromo-N, N-diphenylaniline (34.2 g, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g, 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain BOC-6 (48.4 g, yield 89%).

1H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20 (dd, 4H), 7.40-7.54 (m, 7H), 7.69-7.87 (m, 3H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20 (dd, 4H), 7.40-7.54 (m, 7H), 7.69-7.87 (m, 3H), 8.05 (d , 2H), 10.1 (b, 1H)

[준비예 24] BOC-7의 합성Preparation 24 Synthesis of BOC-7

Figure PCTKR2015000699-appb-I000088
Figure PCTKR2015000699-appb-I000088

질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-oxazolo[5,4-a]carbazole (64.1 g, 156.2 mmol), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (62.6 g, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 mmol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 BOC-7 (75.4 g, 수율 85%)을 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-oxazolo [5,4-a] carbazole (64.1 g, 156.2 mmol) under nitrogen stream ), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (62.6 g, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g , 390.5 mmol), 1,4-dioxane / H 2 O (160 ml / 40 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain BOC-7 (75.4 g, yield 85%).

1H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73 (dd, 1H), 6.81 (t, 1H), 7.02-7.05 (m, 2H), 7.20-7.23 (m, 3H), 7.36-7.41 (m, 2H), 7.51-7.69 (m, 4H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05-8.12 (m, 3H), 10.1 (b, 1H) 1 H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73 (dd, 1H), 6.81 (t, 1H), 7.02-7.05 (m, 2H), 7.20-7.23 (m, 3H), 7.36-7.41 (m, 2H), 7.51-7.69 (m, 4H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05-8.12 (m, 3H), 10.1 (b, 1H)

[준비예 25] BOC-8의 합성Preparation 25 Synthesis of BOC-8

Figure PCTKR2015000699-appb-I000089
Figure PCTKR2015000699-appb-I000089

질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-oxazolo[4,5-b]carbazole (39.4 g, 96.0 mmol), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (38.5 g, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 BOC-8 (45.2 g, 수율 83%)을 얻었다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-oxazolo [4,5-b] carbazole (39.4 g, 96.0 mmol) under nitrogen stream ), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (38.5 g, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g , 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain BOC-8 (45.2 g, yield 83%).

1H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73-6.81 (m, 2H), 7.02-7.05 (m, 2H), 7.20 (dd, 2H), 7.36-7.41 (m, 3H), 7.51-7.55 (m, 3H), 7.61 (s, 1H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73-6.81 (m, 2H), 7.02-7.05 (m, 2H), 7.20 (dd, 2H), 7.36-7.41 ( m, 3H), 7.51-7.55 (m, 3H), 7.61 (s, 1H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.05 (d, 2H), 10.1 (b, 1H)

[준비예 26] BTC-1 & BTC-2의 합성Preparation 26 Synthesis of BTC-1 & BTC-2

<단계 1> N-(2,4-dibromophenyl)benzothioamide의 합성Step 1 Synthesis of N- (2,4-dibromophenyl) benzothioamide

Figure PCTKR2015000699-appb-I000090
Figure PCTKR2015000699-appb-I000090

반응기에 N-(2,4-dibromophenyl)benzamide (266.2 g, 0.75 mol)을 투입하고, toluene (3,000 ml)를 가한 후 교반하였다. 반응기에 Lawesson's reagent (229.2 g, 0.53 mol)를 적가하고 110℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출한 다음 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 N-(2,4-dibromophenyl)benzothioamide (263.5 g, 수율 95%)를 얻었다.N- (2,4-dibromophenyl) benzamide (266.2 g, 0.75 mol) was added to the reactor, and toluene (3,000 ml) was added thereto, followed by stirring. Lawesson's reagent (229.2 g, 0.53 mol) was added dropwise to the reactor and stirred at 110 ° C. for 4 hours. After completion of the reaction, the mixture was extracted with methylene chloride and then water was removed with MgSO 4 , purified by column chromatography (Hexane: EA = 7: 1 (v / v)) and purified by N- (2,4-dibromophenyl) benzothioamide ( 263.5 g, yield 95%).

1H-NMR: δ 6.41 (d, 1H), 7.29 (d, 1H), 7.44-7.45 (m, 3H), 7.75 (s, 1H), 7.98 (d, 2H), 8.59 (b, 1H) 1 H-NMR: δ 6.41 (d, 1H), 7.29 (d, 1H), 7.44-7.45 (m, 3H), 7.75 (s, 1H), 7.98 (d, 2H), 8.59 (b, 1H)

<단계 2> 6-bromo-2-phenylbenzo[d]thiazole의 합성<Step 2> Synthesis of 6-bromo-2-phenylbenzo [d] thiazole

Figure PCTKR2015000699-appb-I000091
Figure PCTKR2015000699-appb-I000091

질소 기류 하에서 N-(2,4-dibromophenyl)benzothioamide (263.5 g, 710 mmol), K2CO3 (196.3 g, 1420 mmol) 및 DMSO (7100 ml)를 혼합하고 140℃에서 1.5시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 6-bromo-2-phenylbenzo[d]thiazole (156.6 g, 수율 76%)을 얻었다.N- (2,4-dibromophenyl) benzothioamide (263.5 g, 710 mmol), K 2 CO 3 (196.3 g, 1420 mmol) and DMSO (7100 ml) were mixed under nitrogen stream and stirred at 140 ° C. for 1.5 hours. After completion of the reaction, the mixture was extracted with ethyl acetate, followed by removing water with MgSO 4 , and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 6-bromo-2-phenylbenzo [d] thiazole ( 156.6 g, yield 76%) was obtained.

1H-NMR: δ 7.41 (t, 1H) 7.51 (dd, 2H), 7.64 (d, 1H), 7.72 (d, 1H), 8.03 (d, 2H), 8.83 (s, 1H) 1 H-NMR: δ 7.41 (t, 1H) 7.51 (dd, 2H), 7.64 (d, 1H), 7.72 (d, 1H), 8.03 (d, 2H), 8.83 (s, 1H)

<단계 3> 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole의 합성<Step 3> Synthesis of 2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole

Figure PCTKR2015000699-appb-I000092
Figure PCTKR2015000699-appb-I000092

질소 기류 하에서 6-bromo-2-phenylbenzo[d]thiazole (156.6 g, 540.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd(dppf)Cl2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) 및 1,4-Dioxane (2800 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole (140.2 g, 수율 77%)을 얻었다.6-bromo-2-phenylbenzo [d] thiazole (156.6 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi under nitrogen stream (1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4-Dioxane (2800 ml) Mix and stir at 130 ° C. for 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to 2-phenyl-6- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole (140.2 g, yield 77%) was obtained.

1H-NMR: δ 1.24 (s, 12H) 7.38 (d, 1H), 7.41 (t, 1H), 7.51 (dd, 2H), 7.75 (d, 1H), 7.95 (s, 1H), 8.03 (d, 2H) 1 H-NMR: δ 1.24 (s, 12H) 7.38 (d, 1H), 7.41 (t, 1H), 7.51 (dd, 2H), 7.75 (d, 1H), 7.95 (s, 1H), 8.03 (d , 2H)

<단계 4> 6-(2-nitrophenyl)-2-phenylbenzo[d]thiazole의 합성Step 4 Synthesis of 6- (2-nitrophenyl) -2-phenylbenzo [d] thiazole

Figure PCTKR2015000699-appb-I000093
Figure PCTKR2015000699-appb-I000093

질소 기류 하에서 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole (140.2 g, 415.7 mmol), 1-bromo-2-nitrobenzene (92.4 g, 457.4 mmol), Pd(PPh3)4 (24.0 g, 20.8 mmol), K2CO3 (143.7 g, 1.04 mol), 1,4-dioxane/H2O (400 ml/100 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 6:1 (v/v))로 정제하여 6-(2-nitrophenyl)-2-phenylbenzo[d]thiazole (116.1 g, 수율 84%)을 얻었다.2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole (140.2 g, 415.7 mmol), 1-bromo-2 under nitrogen stream -nitrobenzene (92.4 g, 457.4 mmol), Pd (PPh 3 ) 4 (24.0 g, 20.8 mmol), K 2 CO 3 (143.7 g, 1.04 mol), 1,4-dioxane / H 2 O (400 ml / 100 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography (Hexane: EA = 6: 1 (v / v)) to give 6- (2-nitrophenyl) -2-phenylbenzo [d] thiazole (116.1 g, 84% yield). Got.

1H-NMR: δ 7.41-7.51 (m, 3H), 7.67 (dd, 1H), 7.77-7.90 (m, 3H), 8.00-8.05 (m, 4H), 8.34 (s, 1H) 1 H-NMR: δ 7.41-7.51 (m, 3H), 7.67 (dd, 1H), 7.77-7.90 (m, 3H), 8.00-8.05 (m, 4H), 8.34 (s, 1H)

<단계 5> BTC-1과 BTC-2의 합성Step 5 Synthesis of BTC-1 and BTC-2

Figure PCTKR2015000699-appb-I000094
Figure PCTKR2015000699-appb-I000094

질소 기류 하에서 6-(2-nitrophenyl)-2-phenylbenzo[d]thiazole (116.1 g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol), 1,2-dichlorobenzene 1500 ml를 넣은 후 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 6:1 (v/v))로 정제하여 BTC-1 (55.6 g, 수율 53 %)과 BTC-2 (38.8g, 수율 37 %)를 획득하였다.6- (2-nitrophenyl) -2-phenylbenzo [d] thiazole (116.1 g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol) and 1,2-dichlorobenzene under nitrogen were added thereto and stirred for 12 hours. . After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: MC = 6: 1 (v / v)) to obtain BTC-1 (55.6 g, yield 53%) and BTC-2 (38.8g, yield 37%). Obtained.

BTC-1의 1H-NMR: δ 7.29 (dd, 1H), 7.41-7.63 (m, 6H), 7.75 (d, 1H), 8.03-8.12 (m, 3H), 10.1 (b, 1H) 1 H-NMR of BTC-1: δ 7.29 (dd, 1H), 7.41-7.63 (m, 6H), 7.75 (d, 1H), 8.03-8.12 (m, 3H), 10.1 (b, 1H)

BTC-2의 1H-NMR: δ 7.29 (dd, 1H), 7.41-7.51 (m, 4H), 7.63 (d, 1H), 8.03-8.12 (m, 4H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR of BTC-2: δ 7.29 (dd, 1H), 7.41-7.51 (m, 4H), 7.63 (d, 1H), 8.03-8.12 (m, 4H), 8.23 (s, 1H), 10.1 (b, 1H)

[준비예 27] BTC-3의 합성Preparation 27 Synthesis of BTC-3

<단계 1> 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]thiazole의 합성<Step 1> Synthesis of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] thiazole

Figure PCTKR2015000699-appb-I000095
Figure PCTKR2015000699-appb-I000095

질소 기류 하에서 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole (140.2 g, 415.7 mmol), 4-bromo-2-iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd(PPh3)4 (24.0 g, 20.8 mmol), K2CO3 (143.7 g, 1.04 mol), 1,4-dioxane/H2O (400 ml/100 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]thiazole (143.5 g, 수율 84%)을 얻었다.2-phenyl-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo [d] thiazole (140.2 g, 415.7 mmol), 4-bromo-2 under nitrogen stream -iodo-1-nitrobenzene (150.0 g, 457.4 mmol), Pd (PPh 3 ) 4 (24.0 g, 20.8 mmol), K 2 CO 3 (143.7 g, 1.04 mol), 1,4-dioxane / H 2 O ( 400 ml / 100 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to give 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] thiazole (143.5 g, Yield 84%).

1H-NMR: δ 7.41 (t, 1H), 7.51 (dd, 2H), 7.72 (s, 1H), 7.77 (d, 1H), 7.81 (d, 1H), 7.98 (d, 1H), 8.03 (d, 2H), 8.21 (d, 1H), 8.34 (s, 1H) 1 H-NMR: δ 7.41 (t, 1H), 7.51 (dd, 2H), 7.72 (s, 1H), 7.77 (d, 1H), 7.81 (d, 1H), 7.98 (d, 1H), 8.03 ( d, 2H), 8.21 (d, 1H), 8.34 (s, 1H)

<단계 2> 7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole과 8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole의 합성Step 2 Synthesis of 7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole with 8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole

Figure PCTKR2015000699-appb-I000096
Figure PCTKR2015000699-appb-I000096

질소 기류 하에서 6-(5-bromo-2-nitrophenyl)-2-phenylbenzo[d]thiazole (143.5g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol), 1,2-dichlorobenzene 1500 ml를 넣은 후 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 5:1 (v/v))로 정제하여 7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole (73.2 g, 수율 55 %)와 8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole (42.8g, 수율 32 %)를 획득하였다.1,500 ml of 6- (5-bromo-2-nitrophenyl) -2-phenylbenzo [d] thiazole (143.5 g, 349 mmol), triphenylphosphine (274.6 g, 1047 mmol) and 1,2-dichlorobenzene under nitrogen stream Stir for hours. After the reaction was completed, 1,2-dichlorobenzene was removed, extracted with dichloromethane, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain 7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole (73.2 g, Yield 55%) and 8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole (42.8g, yield 32%).

7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole의 1H-NMR: δ 7.41-7.42 (m, 2H), 7.51-7.55 (m, 4H), 7.75 (d, 1H), 8.03-8.05 (m, 3H), 10.1 (b, 1H) 1 H-NMR of 7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole: δ 7.41-7.42 (m, 2H), 7.51-7.55 (m, 4H), 7.75 (d, 1H) , 8.03-8.05 (m, 3H), 10.1 (b, 1H)

8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole의 1H-NMR: δ 7.41-7.42 (m, 2H), 7.51-7.55 (m, 3H), 8.03 (d, 2H), 8.05 (s, 1H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR of 8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole: δ 7.41-7.42 (m, 2H), 7.51-7.55 (m, 3H), 8.03 (d, 2H) , 8.05 (s, 1H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)

<단계 3> 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole의 합성<Step 3> Synthesis of 2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole

Figure PCTKR2015000699-appb-I000097
Figure PCTKR2015000699-appb-I000097

질소 기류 하에서 7-bromo-2-phenyl-10H-thiazolo[5,4-a]carbazole (73.2 g, 193.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd(dppf)Cl2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) 및 1,4-Dioxane (1000 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 수율 81%)을 얻었다.7-bromo-2-phenyl-10H-thiazolo [5,4-a] carbazole (73.2 g, 193.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'- under nitrogen stream octamethyl-2,2'-bi (1,3,2-dioxaborolane) (53.9 g, 212.3 mmol), Pd (dppf) Cl 2 (22.3 g, 19.3 mmol), KOAc (54.5 g, 579 mmol) and 1, 4-Dioxane (1000 ml) was mixed and stirred at 130 ° C. for 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to 2-phenyl-7- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (66.6 g, yield 81%) was obtained.

1H-NMR: δ 1.24 (s, 12H) 7.41 (t, 1H), 7.51-7.55 (m, 4H), 7.63 (d, 1H), 7.75 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (t, 1H), 7.51-7.55 (m, 4H), 7.63 (d, 1H), 7.75 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 10.1 (b, 1H)

<단계 4> BTC-3의 합성Step 4 Synthesis of BTC-3

Figure PCTKR2015000699-appb-I000098
Figure PCTKR2015000699-appb-I000098

질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 156.2 mmol), iodobenzene (19.1 mL, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 m mol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 BTC-3 (50.0 g, 수율 85%)을 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (66.6 g, 156.2 mmol) under a nitrogen stream ), iodobenzene (19.1 mL, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g, 390.5 m mol), 1,4-dioxane / H 2 O (160 ml / 40 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain BTC-3 (50.0 g, yield 85%).

1H-NMR: δ 7.41-7.55 (m, 9H), 7.69- 7.77 (m, 3H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 7.41-7.55 (m, 9H), 7.69-7.77 (m, 3H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H)

[준비예 28] BTC-4의 합성Preparation 28 Synthesis of BTC-4

<단계 1> 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole의 합성<Step 1> Synthesis of 2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole

Figure PCTKR2015000699-appb-I000099
Figure PCTKR2015000699-appb-I000099

질소 기류 하에서 8-bromo-2-phenyl-5H-thiazolo[4,5-b]carbazole (42.8 g, 112.8 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd(dppf)Cl2 (13.1 g, 11.3 mmol), KOAc (31.9 g, 338.7 mmol) 및 1,4-Dioxane (700 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 수율 85%)을 얻었다.8-bromo-2-phenyl-5H-thiazolo [4,5-b] carbazole (42.8 g, 112.8 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'- under nitrogen stream octamethyl-2,2'-bi (1,3,2-dioxaborolane) (31.5 g, 124.2 mmol), Pd (dppf) Cl 2 (13.1 g, 11.3 mmol), KOAc (31.9 g, 338.7 mmol) and 1, 4-Dioxane (700 ml) was mixed and stirred at 130 ° C. for 12 h. After the reaction was completed, the mixture was extracted with ethyl acetate, followed by removing moisture with MgSO 4 , and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to 2-phenyl-8- (4,4,5 , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (40.9 g, yield 85%) was obtained.

1H-NMR: δ 1.24 (s, 12H) 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 1.24 (s, 12H) 7.41 (t, 1H), 7.50-7.51 (m, 3H), 7.63 (d, 1H), 7.98 (s, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)

<단계 2> BTC-4의 합성<Step 2> Synthesis of BTC-4

Figure PCTKR2015000699-appb-I000100
Figure PCTKR2015000699-appb-I000100

질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 96.0 mmol), iodobenzene (11.8 mL, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 BTC-4 (30.4 g, 수율 84%)를 얻었다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (40.9 g, 96.0 mmol under nitrogen stream ), iodobenzene (11.8 mL, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g, 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain BTC-4 (30.4 g, yield 84%).

1H-NMR: δ 7.41-7.52 (m, 8H), 7.69 (d,1H) 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 7.41-7.52 (m, 8H), 7.69 (d, 1H) 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)

[준비예 29] BTC-5의 합성Preparation Example 29 Synthesis of BTC-5

Figure PCTKR2015000699-appb-I000101
Figure PCTKR2015000699-appb-I000101

질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 156.2 mmol), 4-bromo-N,N-diphenylaniline (55.7 g, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 mmol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 BTC-5 (72.2 g, 수율 85%)를 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (66.6 g, 156.2 mmol) under a nitrogen stream ), 4-bromo-N, N-diphenylaniline (55.7 g, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g, 390.5 mmol), 1,4-dioxane / H 2 O (160 ml / 40 ml) was mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain BTC-5 (72.2 g, yield 85%).

1H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20 (dd, 4H), 7.41 (t, 1H), 7.51-7.55 (m, 5H), 7.69 (d, 1H), 7.75 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20 (dd, 4H), 7.41 (t, 1H), 7.51-7.55 (m, 5H), 7.69 (d, 1H ), 7.75 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H)

[준비예 30] BTC-6의 합성Preparation Example 30 Synthesis of BTC-6

Figure PCTKR2015000699-appb-I000102
Figure PCTKR2015000699-appb-I000102

질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 96.0 mmol), 4-bromo-N,N-diphenylaniline (34.2 g, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 BTC-6 (42.8 g, 수율 81%)을 얻었다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (40.9 g, 96.0 mmol under nitrogen stream ), 4-bromo-N, N-diphenylaniline (34.2 g, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g, 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) was mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain BTC-6 (42.8 g, yield 81%).

1H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20 (dd, 4H), 7.41 (t, 1H), 7.51-7.54 (m, 4H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 6.63-6.69 (m, 6H), 6.81 (t, 2H), 7.20 (dd, 4H), 7.41 (t, 1H), 7.51-7.54 (m, 4H), 7.69 (d, 1H ), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H)

[준비예 31] BTC-7의 합성Preparation Example 31 Synthesis of BTC-7

Figure PCTKR2015000699-appb-I000103
Figure PCTKR2015000699-appb-I000103

질소 기류 하에서 2-phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-thiazolo[5,4-a]carbazole (66.6 g, 156.2 mmol), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (62.6 g, 171.8 mmol), Pd(PPh3)4 (9.02 g, 7.81 mmol), K2CO3(53.8 g, 390.5 mmol), 1,4-dioxane/H2O (160 ml/40 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 12:1 (v/v))로 정제하여 BTC-7 (79.3 g, 수율 87%)을 얻었다.2-phenyl-7- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -10H-thiazolo [5,4-a] carbazole (66.6 g, 156.2 mmol) under a nitrogen stream ), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (62.6 g, 171.8 mmol), Pd (PPh 3 ) 4 (9.02 g, 7.81 mmol), K 2 CO 3 (53.8 g , 390.5 mmol), 1,4-dioxane / H 2 O (160 ml / 40 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography (Hexane: EA = 12: 1 (v / v)) to obtain BTC-7 (79.3 g, yield 87%).

1H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73 (dd, 1H), 6.81 (t, 1H), 7.02-7.05 (m, 2H), 7.20 (dd, 2H), 7.36 (d, 1H), 7.41 (t, 1H), 7.51-7.61 (m, 4H), 7.69-7.75 (m, 3H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b, 1H) 1 H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73 (dd, 1H), 6.81 (t, 1H), 7.02-7.05 (m, 2H), 7.20 (dd, 2H) , 7.36 (d, 1H), 7.41 (t, 1H), 7.51-7.61 (m, 4H), 7.69-7.75 (m, 3H), 7.87 (d, 1H), 8.03 (d, 2H), 10.1 (b , 1H)

[준비예 32] BTC-8의 합성Preparation 32 Synthesis of BTC-8

Figure PCTKR2015000699-appb-I000104
Figure PCTKR2015000699-appb-I000104

질소 기류 하에서 2-phenyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-thiazolo[4,5-b]carbazole (40.9 g, 96.0 mmol), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (38.5 g, 105.6 mmol), Pd(PPh3)4 (5.55 g, 4.80 mmol), K2CO3(39.8 g, 288 mmol), 1,4-dioxane/H2O (100 ml/25 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 BTC-8 (45.4 g, 수율 81%)을 얻었다.2-phenyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-thiazolo [4,5-b] carbazole (40.9 g, 96.0 mmol under nitrogen stream ), 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine (38.5 g, 105.6 mmol), Pd (PPh 3 ) 4 (5.55 g, 4.80 mmol), K 2 CO 3 (39.8 g , 288 mmol), 1,4-dioxane / H 2 O (100 ml / 25 ml) were mixed and stirred at 120 ° C. for 4 hours. After the reaction was terminated and extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the obtained organic layer was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to give BTC-8 (45.4 g, 81% yield).

1H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73-6.81 (m, 2H), 7.02-7.05 (m, 2H), 7.20 (dd, 2H), 7.36-7.61 (m, 5H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b, 1H) 1 H-NMR: δ 1.72 (s, 6H) 6.55-6.63 (m, 4H), 6.73-6.81 (m, 2H), 7.02-7.05 (m, 2H), 7.20 (dd, 2H), 7.36-7.61 ( m, 5H), 7.69 (d, 1H), 7.77 (s, 1H), 7.87 (d, 1H), 8.03 (d, 2H), 8.12 (s, 1H), 8.23 (s, 1H), 10.1 (b , 1H)

[합성예 1] Inv-1의 합성Synthesis Example 1 Synthesis of Inv-1

Figure PCTKR2015000699-appb-I000105
Figure PCTKR2015000699-appb-I000105

질소 기류 하에서 PC-1 (3 g, 10.63 mmol), 3'-Bromo-biphenyl-4-carbonitrile (2.89 g, 11.20 mmol), Pd(OAc)2 (0.12 g, 5 mol%), NaO(t-bu) (2.04 g, 21.25 mmol), P(t-bu)3 (0.21 g, 1.06 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 목적 화합물인 Inv-1 (4.02 g, 수율 82 %)을 얻었다.PC-1 (3 g, 10.63 mmol), 3'-Bromo-biphenyl-4-carbonitrile (2.89 g, 11.20 mmol), Pd (OAc) 2 (0.12 g, 5 mol%), NaO (t-) under nitrogen stream bu) (2.04 g, 21.25 mmol), P (t-bu) 3 (0.21 g, 1.06 mmol) and Toluene (100 ml) were mixed and stirred at 110 ° C. for 12 h. After completion of the reaction, the mixture was extracted with ethyl acetate and then water was removed with MgSO 4 , and purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain Inv-1 (4.02 g, yield 82). %) Was obtained.

GC-Mass (이론치: 459.54 g/mol, 측정치: 459 g/mol)GC-Mass (Theoretical value: 459.54 g / mol, Measured value: 459 g / mol)

[합성예 2] Inv-2의 합성Synthesis Example 2 Synthesis of Inv-2

Figure PCTKR2015000699-appb-I000106
Figure PCTKR2015000699-appb-I000106

3'-Bromo-biphenyl-4-carbonitrile 대신 3'-Bromo-biphenyl-3,5-dicarbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-2 (3.45 g, 67 %)를 얻었다.Except for using 3'-Bromo-biphenyl-3,5-dicarbonitrile instead of 3'-Bromo-biphenyl-4-carbonitrile was carried out in the same manner as in Synthesis Example 1 Inv-2 (3.45 g, 67%).

GC-Mass (이론치: 484.55 g/mol, 측정치: 484 g/mol)GC-Mass (Theoretical value: 484.55 g / mol, Measured value: 484 g / mol)

[합성예 3] Inv-3의 합성Synthesis Example 3 Synthesis of Inv-3

Figure PCTKR2015000699-appb-I000107
Figure PCTKR2015000699-appb-I000107

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-2와 3'-Bromo-biphenyl-3-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-3 (4.15 g, 85 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that PC-2 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -3 (4.15 g, 85%) was obtained.

GC-Mass (이론치: 459.54 g/mol, 측정치: 459 g/mol)GC-Mass (Theoretical value: 459.54 g / mol, Measured value: 459 g / mol)

[합성예 4] Inv-4의 합성Synthesis Example 4 Synthesis of Inv-4

Figure PCTKR2015000699-appb-I000108
Figure PCTKR2015000699-appb-I000108

PC-1 대신 PC-3을 3'-Bromo-biphenyl-4-carbonitrile 대신 3'-Bromo-biphenyl-3-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-4 (3.71 g, 76 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that 3'-Bromo-biphenyl-3-carbonitrile was used instead of 3'-Bromo-biphenyl-4-carbonitrile instead of PC-1. -4 (3.71 g, 76%) was obtained.

GC-Mass (이론치: 459.54 g/mol, 측정치: 459 g/mol)GC-Mass (Theoretical value: 459.54 g / mol, Measured value: 459 g / mol)

[합성예 5] Inv-5의 합성Synthesis Example 5 Synthesis of Inv-5

Figure PCTKR2015000699-appb-I000109
Figure PCTKR2015000699-appb-I000109

PC-1 대신 PC-4를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-5 (4.20 g, 86 %)를 얻었다.Except for using PC-4 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-5 (4.20 g, 86%).

GC-Mass (이론치: 459.54 g/mol, 측정치: 459 g/mol)GC-Mass (Theoretical value: 459.54 g / mol, Measured value: 459 g / mol)

[합성예 6] Inv-6의 합성Synthesis Example 6 Synthesis of Inv-6

Figure PCTKR2015000699-appb-I000110
Figure PCTKR2015000699-appb-I000110

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-5와 8-Bromo-dibenzothiophene-2-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-6 (3.28 g, 63 %)를 얻었다.Inv-, the target compound, was prepared in the same manner as in Synthesis Example 1, except that PC-5 and 8-Bromo-dibenzothiophene-2-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. 6 (3.28 g, 63%) was obtained.

GC-Mass (이론치: 489.59 g/mol, 측정치: 489 g/mol)GC-Mass (Theoretical value: 489.59 g / mol, Measured value: 489 g / mol)

[합성예 7] Inv-7의 합성Synthesis Example 7 Synthesis of Inv-7

Figure PCTKR2015000699-appb-I000111
Figure PCTKR2015000699-appb-I000111

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-6과 8-Bromo-dibenzofuran-2-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-7 (3.07 g, 61 %)를 얻었다.Inv- as a target compound was performed in the same manner as in Synthesis Example 1, except that PC-6 and 8-Bromo-dibenzofuran-2-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. 7 (3.07 g, 61%) was obtained.

GC-Mass (이론치: 473.52 g/mol, 측정치: 473 g/mol)GC-Mass (Theoretical value: 473.52 g / mol, Measured value: 473 g / mol)

[합성예 8] Inv-8의 합성Synthesis Example 8 Synthesis of Inv-8

Figure PCTKR2015000699-appb-I000112
Figure PCTKR2015000699-appb-I000112

질소 기류 하에서 PC-7 (5 g, 13.84 mmol), phenylboronic acid (2.03 g, 16.61 mmol), NaOH (1.66 g, 41.52 mmol) 및 THF/H2O(100 ml/500 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(0.80 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 PC-7-1을 얻었다. 이후, PC-1 대신 PC-7-1을 사용하여 상기 합성예 1과 동일한 과정을 거쳐 목적 화합물인 Inv-8 (4.67 g, 82 %)를 얻었다.Under nitrogen stream, mix PC-7 (5 g, 13.84 mmol), phenylboronic acid (2.03 g, 16.61 mmol), NaOH (1.66 g, 41.52 mmol) and THF / H 2 O (100 ml / 500 ml), Pd (PPh 3 ) 4 (0.80 g, 5 mol%) was added at 40 ° C. and stirred at 80 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain PC-7-1. Thereafter, PC-7-1 was used instead of PC-1 to obtain Inv-8 (4.67 g, 82%) as a target compound.

GC-Mass (이론치: 535.64 g/mol, 측정치: 535 g/mol)GC-Mass (Theoretical value: 535.64 g / mol, Measured value: 535 g / mol)

[합성예 9] Inv-9의 합성Synthesis Example 9 Synthesis of Inv-9

Figure PCTKR2015000699-appb-I000113
Figure PCTKR2015000699-appb-I000113

phenylboronic acid 대신 9-phenyl-9H-carbazol-3-ylboronic acid을 사용하는 것을 제외하고는 상기 합성예 8과 동일한 과정을 수행하여 목적 화합물인 Inv-9 (5.59 g, 75 %)를 얻었다.Inv-9 (5.59 g, 75%) was obtained by the same procedure as in Synthesis Example 8, except that 9-phenyl-9H-carbazol-3-ylboronic acid was used instead of phenylboronic acid.

GC-Mass (이론치: 700.83 g/mol, 측정치: 700 g/mol)GC-Mass (Theoretical value: 700.83 g / mol, Measured value: 700 g / mol)

[합성예 10] Inv-10의 합성Synthesis Example 10 Synthesis of Inv-10

Figure PCTKR2015000699-appb-I000114
Figure PCTKR2015000699-appb-I000114

PC-1 대신 PC-8을 사용하는 것을 제외하고는 상기 합성예 8과 동일한 과정을 수행하여 목적 화합물인 Inv-10 (4.44 g, 78%)를 얻었다.Exc 10 (4.44 g, 78%) was obtained by the same procedure as in Synthesis Example 8, except that PC-8 was used instead of PC-1.

GC-Mass (이론치: 535.64 g/mol, 측정치: 535 g/mol)GC-Mass (Theoretical value: 535.64 g / mol, Measured value: 535 g / mol)

[합성예 11] Inv-11의 합성Synthesis Example 11 Synthesis of Inv-11

Figure PCTKR2015000699-appb-I000115
Figure PCTKR2015000699-appb-I000115

PC-1과 phenylboronic acid 대신 PC-8과 9-(4,6-diphenylpyridin-2-yl)-9H-carbazol-3-ylboronic acid을 사용하는 것을 제외하고는 상기 합성예 8과 동일한 과정을 수행하여 목적 화합물인 Inv-11 (6.90 g, 76 %)를 얻었다.The same procedure as in Synthesis Example 8 was performed except that PC-8 and 9- (4,6-diphenylpyridin-2-yl) -9H-carbazol-3-ylboronic acid were used instead of PC-1 and phenylboronic acid. Inv-11 (6.90 g, 76%) was obtained as the target compound.

GC-Mass (이론치: 854.01 g/mol, 측정치: 854 g/mol)GC-Mass (Theoretical value: 854.01 g / mol, Measured value: 854 g / mol)

[합성예 12] Inv-12의 합성Synthesis Example 12 Synthesis of Inv-12

Figure PCTKR2015000699-appb-I000116
Figure PCTKR2015000699-appb-I000116

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-9와 4-Bromo-benzonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-12 (3.32 g, 68 %)를 얻었다.Inv-12 (3.32 g) was prepared by the same procedure as in Synthesis Example 1, except that PC-9 and 4-Bromo-benzonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. , 68%).

GC-Mass (이론치: 459.54 g/mol, 측정치: 459 g/mol)GC-Mass (Theoretical value: 459.54 g / mol, Measured value: 459 g / mol)

[합성예 13] Inv-13의 합성Synthesis Example 13 Synthesis of Inv-13

Figure PCTKR2015000699-appb-I000117
Figure PCTKR2015000699-appb-I000117

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-10와 3'-Bromo-biphenyl-3,5-dicarbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-13 (3.75 g, 63 %)를 얻었다.Except for using PC-10 and 3'-Bromo-biphenyl-3,5-dicarbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile was carried out the same procedure as in Synthesis Example 1 Phosphorus Inv-13 (3.75 g, 63%) was obtained.

GC-Mass (이론치: 560.65 g/mol, 측정치: 560 g/mol)GC-Mass (Theoretical value: 560.65 g / mol, Measured value: 560 g / mol)

[합성예 14] Inv-14의 합성Synthesis Example 14 Synthesis of Inv-14

Figure PCTKR2015000699-appb-I000118
Figure PCTKR2015000699-appb-I000118

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-11와 3'-Bromo-biphenyl-3-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-14 (3.75 g, 63 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that PC-11 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -14 (3.75 g, 63%) was obtained.

GC-Mass (이론치: 535.64 g/mol, 측정치: 535 g/mol)GC-Mass (Theoretical value: 535.64 g / mol, Measured value: 535 g / mol)

[합성예 15] Inv-15의 합성Synthesis Example 15 Synthesis of Inv-15

Figure PCTKR2015000699-appb-I000119
Figure PCTKR2015000699-appb-I000119

PC-1 대신 PC-12를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-15 (3.75 g, 78 %)를 얻었다.Except for using PC-12 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-15 (3.75 g, 78%).

GC-Mass (이론치: 611.73 g/mol, 측정치: 611 g/mol)GC-Mass (Theoretical value: 611.73 g / mol, Measured value: 611 g / mol)

[합성예 16] Inv-16의 합성Synthesis Example 16 Synthesis of Inv-16

Figure PCTKR2015000699-appb-I000120
Figure PCTKR2015000699-appb-I000120

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 PC-13과 3-Bromo-benzonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-16 (3.47 g, 61 %)를 얻었다.Inv-16 (3.47 g) was prepared by the same procedure as in Synthesis Example 1, except that PC-13 and 3-Bromo-benzonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. , 61%).

GC-Mass (이론치: 535.64 g/mol, 측정치: 535 g/mol)GC-Mass (Theoretical value: 535.64 g / mol, Measured value: 535 g / mol)

[합성예 17] Inv-17의 합성Synthesis Example 17 Synthesis of Inv-17

Figure PCTKR2015000699-appb-I000121
Figure PCTKR2015000699-appb-I000121

PC-1 대신 IC-1를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-17 (3.47 g, 61 %)를 얻었다.Exc-17 (3.47 g, 61%) was obtained by the same procedure as in Synthesis Example 1, except that IC-1 was used instead of PC-1.

GC-Mass (이론치: 460.53 g/mol, 측정치: 460 g/mol)GC-Mass (Theoretical value: 460.53 g / mol, Measured value: 460 g / mol)

[합성예 18] Inv-18의 합성Synthesis Example 18 Synthesis of Inv-18

Figure PCTKR2015000699-appb-I000122
Figure PCTKR2015000699-appb-I000122

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 IC-1와 5-bromo-1,1',3',1''-Terphenyl-4,4''-dicarbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-18 (3.94 g, 66 %)를 얻었다.Except for using IC-1 and 5-bromo-1,1 ', 3', 1 ''-Terphenyl-4,4 ''-dicarbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile Was carried out in the same manner as in Synthesis Example 1 to obtain Inv-18 (3.94 g, 66%) as a target compound.

GC-Mass (이론치: 561.63 g/mol, 측정치: 561 g/mol)GC-Mass (Theoretical value: 561.63 g / mol, Measured value: 561 g / mol)

[합성예 19] Inv-19의 합성Synthesis Example 19 Synthesis of Inv-19

Figure PCTKR2015000699-appb-I000123
Figure PCTKR2015000699-appb-I000123

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 IC-2와 4'-Bromo-biphenyl-3-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-19(4.01g, 82 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that IC-2 and 4'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -19 (4.01 g, 82%) was obtained.

GC-Mass (이론치: 460.53 g/mol, 측정치: 460 g/mol)GC-Mass (Theoretical value: 460.53 g / mol, Measured value: 460 g / mol)

[합성예 20] Inv-20의 합성Synthesis Example 20 Synthesis of Inv-20

Figure PCTKR2015000699-appb-I000124
Figure PCTKR2015000699-appb-I000124

PC-1 대신 IC-3를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-20 (3.72 g, 76 %)를 얻었다.Exc-20 (3.72 g, 76%) was obtained by the same procedure as in Synthesis Example 1, except that IC-3 was used instead of PC-1.

GC-Mass (이론치: 460.53 g/mol, 측정치: 460 g/mol)GC-Mass (Theoretical value: 460.53 g / mol, Measured value: 460 g / mol)

[합성예 21] Inv-21의 합성Synthesis Example 21 Synthesis of Inv-21

Figure PCTKR2015000699-appb-I000125
Figure PCTKR2015000699-appb-I000125

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 IC-4와 7-Bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-21 (3.99, 75 %)를 얻었다.The same procedure as in Synthesis Example 1 except for using IC-4 and 7-Bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile Inv-21 (3.99, 75%) was obtained as the target compound.

GC-Mass (이론치: 500.59 g/mol, 측정치: 500 g/mol)GC-Mass (Theoretical value: 500.59 g / mol, Measured value: 500 g / mol)

[합성예 22] Inv-22의 합성Synthesis Example 22 Synthesis of Inv-22

Figure PCTKR2015000699-appb-I000126
Figure PCTKR2015000699-appb-I000126

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 IC-5와 7-Bromo-triphenylene-2-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-22 (3.86, 68 %)를 얻었다.Inv- as the target compound was carried out in the same manner as in Synthesis Example 1, except that IC-5 and 7-Bromo-triphenylene-2-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. 22 (3.86, 68%) was obtained.

GC-Mass (이론치: 534.61 g/mol, 측정치: 534 g/mol)GC-Mass (Theoretical value: 534.61 g / mol, Measured value: 534 g / mol)

[합성예 23] Inv-23의 합성Synthesis Example 23 Synthesis of Inv-23

Figure PCTKR2015000699-appb-I000127
Figure PCTKR2015000699-appb-I000127

PC-1 대신 BOC-1를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-23 (3.29 g, 67 %)를 얻었다.Exc-23 (3.29 g, 67%) was obtained by the same procedure as in Synthesis Example 1, except that BOC-1 was used instead of PC-1.

GC-Mass (이론치: 461.51 g/mol, 측정치: 461 g/mol)GC-Mass (Theoretical value: 461.51 g / mol, Measured value: 461 g / mol)

[합성예 24] Inv-24의 합성Synthesis Example 24 Synthesis of Inv-24

Figure PCTKR2015000699-appb-I000128
Figure PCTKR2015000699-appb-I000128

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-1과 3'-Bromo-biphenyl-3-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-24 (3.53, 72 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that BOC-1 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -24 (3.53, 72%) was obtained.

GC-Mass (이론치: 461.51 g/mol, 측정치: 461 g/mol)GC-Mass (Theoretical value: 461.51 g / mol, Measured value: 461 g / mol)

[합성예 25] Inv-25의 합성Synthesis Example 25 Synthesis of Inv-25

Figure PCTKR2015000699-appb-I000129
Figure PCTKR2015000699-appb-I000129

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-2와 2'-bromo-9,9'-Spirobi[9H-fluorene]-2-carbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-25 (5.04, 76 %)를 얻었다.Synthesis Example 1 except for using BOC-2 and 2'-bromo-9,9'-Spirobi [9H-fluorene] -2-carbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile Inv-25 (5.04, 76%) as a target compound was obtained.

GC-Mass (이론치: 623.70 g/mol, 측정치: 623 g/mol)GC-Mass (Theoretical value: 623.70 g / mol, Measured value: 623 g / mol)

[합성예 26] Inv-26의 합성Synthesis Example 26 Synthesis of Inv-26

Figure PCTKR2015000699-appb-I000130
Figure PCTKR2015000699-appb-I000130

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-2와 3'-Bromo-biphenyl-3,5-dicarbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-26 (3.26, 63 %)를 얻었다.Except for using BOC-2 and 3'-Bromo-biphenyl-3,5-dicarbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out. Phosphorus Inv-26 (3.26, 63%) was obtained.

GC-Mass (이론치: 486.52 g/mol, 측정치: 486 g/mol)GC-Mass (Theoretical value: 486.52 g / mol, Measured value: 486 g / mol)

[합성예 27] Inv-27의 합성Synthesis Example 27 Synthesis of Inv-27

Figure PCTKR2015000699-appb-I000131
Figure PCTKR2015000699-appb-I000131

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-3과 4-Bromo-benzonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-27 (3.39, 69 %)를 얻었다.Except for using BOC-3 and 4-Bromo-benzonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out to obtain Inv-27 (3.39, 69%).

GC-Mass (이론치: 461.51 g/mol, 측정치: 461 g/mol)GC-Mass (Theoretical value: 461.51 g / mol, Measured value: 461 g / mol)

[합성예 28] Inv-28의 합성Synthesis Example 28 Synthesis of Inv-28

Figure PCTKR2015000699-appb-I000132
Figure PCTKR2015000699-appb-I000132

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-3과 3'-Bromo-biphenyl-3-carbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-28 (4.29, 75 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that BOC-3 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -28 (4.29, 75%) was obtained.

GC-Mass (이론치: 537.61 g/mol, 측정치: 537 g/mol)GC-Mass (Theoretical value: 537.61 g / mol, Measured value: 537 g / mol)

[합성예 29] Inv-29의 합성Synthesis Example 29 Synthesis of Inv-29

Figure PCTKR2015000699-appb-I000133
Figure PCTKR2015000699-appb-I000133

PC-1 대신 BOC-4를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-29 (4.69, 82 %)를 얻었다.Exc-29 (4.69, 82%) was obtained by the same procedure as in Synthesis Example 1, except that BOC-4 was used instead of PC-1.

GC-Mass (이론치: 537.61 g/mol, 측정치: 537 g/mol)GC-Mass (Theoretical value: 537.61 g / mol, Measured value: 537 g / mol)

[합성예 30] Inv-30의 합성Synthesis Example 30 Synthesis of Inv-30

Figure PCTKR2015000699-appb-I000134
Figure PCTKR2015000699-appb-I000134

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-4와 9-(3-Bromo-phenyl)-9H-carbazole-3,6-dicarbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-30 (3.67, 53 %)를 얻었다.Synthesis Example 1 except for using BOC-4 and 9- (3-Bromo-phenyl) -9H-carbazole-3,6-dicarbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile The same procedure was followed to obtain the target compound Inv-30 (3.67, 53%).

GC-Mass (이론치: 651.71 g/mol, 측정치: 651 g/mol)GC-Mass (Theoretical value: 651.71 g / mol, Measured value: 651 g / mol)

[합성예 31] Inv-31의 합성Synthesis Example 31 Synthesis of Inv-31

Figure PCTKR2015000699-appb-I000135
Figure PCTKR2015000699-appb-I000135

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-5와 4-Bromo-benzonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-31 (4.14, 62 %)를 얻었다.Except for using BOC-5 and 4-Bromo-benzonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out to obtain Inv-31 (4.14, 62%).

GC-Mass (이론치: 628.72 g/mol, 측정치: 628 g/mol)GC-Mass (Theoretical value: 628.72 g / mol, Measured value: 628 g / mol)

[합성예 32] Inv-32의 합성Synthesis Example 32 Synthesis of Inv-32

Figure PCTKR2015000699-appb-I000136
Figure PCTKR2015000699-appb-I000136

PC-1 대신 BOC-5를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-32 (4.35, 58 %)를 얻었다.Exc-32 (4.35, 58%) was obtained by the same procedure as in Synthesis Example 1, except that BOC-5 was used instead of PC-1.

GC-Mass (이론치: 704.82 g/mol, 측정치: 704 g/mol)GC-Mass (Theoretical value: 704.82 g / mol, Measured value: 704 g / mol)

[합성예 33] Inv-33의 합성Synthesis Example 33 Synthesis of Inv-33

Figure PCTKR2015000699-appb-I000137
Figure PCTKR2015000699-appb-I000137

PC-1 대신 BOC-6를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-33 (4.57, 61 %)를 얻었다.Exc-33 (4.57, 61%) was obtained by the same procedure as in Synthesis Example 1, except that BOC-6 was used instead of PC-1.

GC-Mass (이론치: 704.82 g/mol, 측정치: 704 g/mol)GC-Mass (Theoretical value: 704.82 g / mol, Measured value: 704 g / mol)

[합성예 34] Inv-34의 합성Synthesis Example 34 Synthesis of Inv-34

Figure PCTKR2015000699-appb-I000138
Figure PCTKR2015000699-appb-I000138

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-7과 4-Bromo-benzonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-34 (4.55, 64 %)를 얻었다.Except for using BOC-7 and 4-Bromo-benzonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out to obtain Inv-34 (4.55, 64%).

GC-Mass (이론치: 668.78 g/mol, 측정치: 668 g/mol)GC-Mass (Theoretical value: 668.78 g / mol, Measured value: 668 g / mol)

[합성예 35] Inv-35의 합성Synthesis Example 35 Synthesis of Inv-35

Figure PCTKR2015000699-appb-I000139
Figure PCTKR2015000699-appb-I000139

PC-1 대신 BOC-8를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-35 (3.80, 48 %)를 얻었다.Except for using BOC-8 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-35 (3.80, 48%).

GC-Mass (이론치: 744.88 g/mol, 측정치: 744 g/mol)GC-Mass (Theoretical value: 744.88 g / mol, Measured value: 744 g / mol)

[합성예 36] Inv-36의 합성Synthesis Example 36 Synthesis of Inv-36

Figure PCTKR2015000699-appb-I000140
Figure PCTKR2015000699-appb-I000140

PC-1 대신 BTC-1를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-36 (3.25 g, 64 %)를 얻었다.Except for using BTC-1 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-36 (3.25 g, 64%).

GC-Mass (이론치: 477.58 g/mol, 측정치: 477 g/mol)GC-Mass (Theoretical value: 477.58 g / mol, Measured value: 477 g / mol)

[합성예 37] Inv-37의 합성Synthesis Example 37 Synthesis of Inv-37

Figure PCTKR2015000699-appb-I000141
Figure PCTKR2015000699-appb-I000141

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-1과 3'-Bromo-biphenyl-3-carbonitrile을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-37 (3.81, 75 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that BTC-1 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -37 (3.81, 75%) was obtained.

GC-Mass (이론치: 477.58 g/mol, 측정치: 477 g/mol)GC-Mass (Theoretical value: 477.58 g / mol, Measured value: 477 g / mol)

[합성예 38] Inv-38의 합성Synthesis Example 38 Synthesis of Inv-38

Figure PCTKR2015000699-appb-I000142
Figure PCTKR2015000699-appb-I000142

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-2와 2'-bromo-9,9'-Spirobi[9H-fluorene]-2-carbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-38 (4.83, 71 %)를 얻었다.Synthesis Example 1 except for using BTC-2 and 2'-bromo-9,9'-Spirobi [9H-fluorene] -2-carbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile Inv-38 (4.83, 71%) was obtained by the same procedure as the target compound.

GC-Mass (이론치: 639.77 g/mol, 측정치: 639 g/mol)GC-Mass (Theoretical value: 639.77 g / mol, Measured value: 639 g / mol)

[합성예 39] Inv-39의 합성Synthesis Example 39 Synthesis of Inv-39

Figure PCTKR2015000699-appb-I000143
Figure PCTKR2015000699-appb-I000143

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-2와 3'-Bromo-biphenyl-3,5-dicarbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-39 (3.10, 58 %)를 얻었다.Except for using BTC-2 and 3'-Bromo-biphenyl-3,5-dicarbonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out. Phosphorus Inv-39 (3.10, 58%) was obtained.

GC-Mass (이론치: 502.59 g/mol, 측정치: 502 g/mol)GC-Mass (Theoretical value: 502.59 g / mol, Measured value: 502 g / mol)

[합성예 40] Inv-40의 합성Synthesis Example 40 Synthesis of Inv-40

Figure PCTKR2015000699-appb-I000144
Figure PCTKR2015000699-appb-I000144

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-3과 4-Bromo-benzonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-40 (3.55, 70 %)를 얻었다.Except for using BTC-3 and 4-Bromo-benzonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out to obtain Inv-40 (3.55, 70%).

GC-Mass (이론치: 477.58 g/mol, 측정치: 477 g/mol)GC-Mass (Theoretical value: 477.58 g / mol, Measured value: 477 g / mol)

[합성예 41] Inv-41의 합성Synthesis Example 41 Synthesis of Inv-41

Figure PCTKR2015000699-appb-I000145
Figure PCTKR2015000699-appb-I000145

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-3과 3'-Bromo-biphenyl-3-carbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-41 (4.47, 76 %)를 얻었다.Inv, a target compound, was prepared in the same manner as in Synthesis Example 1, except that BTC-3 and 3'-Bromo-biphenyl-3-carbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. -41 (4.47, 76%).

GC-Mass (이론치: 553.67 g/mol, 측정치: 553 g/mol)GC-Mass (Theoretical value: 553.67 g / mol, Measured value: 553 g / mol)

[합성예 42] Inv-42의 합성Synthesis Example 42 Synthesis of Inv-42

Figure PCTKR2015000699-appb-I000146
Figure PCTKR2015000699-appb-I000146

PC-1 대신 BTC-4를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-42 (4.65, 79 %)를 얻었다.Except for using BTC-4 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-42 (4.65, 79%).

GC-Mass (이론치: 553.67 g/mol, 측정치: 553 g/mol)GC-Mass (Theoretical value: 553.67 g / mol, Measured value: 553 g / mol)

[합성예 43] Inv-43의 합성Synthesis Example 43 Synthesis of Inv-43

Figure PCTKR2015000699-appb-I000147
Figure PCTKR2015000699-appb-I000147

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-4와 9-(3-Bromo-phenyl)-9H-carbazole-3,6-dicarbonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-43 (3.41, 48 %)를 얻었다.Synthesis Example 1 except that BTC-4 and 9- (3-Bromo-phenyl) -9H-carbazole-3,6-dicarbonitrile were used instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile. The same procedure was followed to obtain the target compound Inv-43 (3.41, 48%).

GC-Mass (이론치: 667.78 g/mol, 측정치: 667 g/mol)GC-Mass (Theoretical value: 667.78 g / mol, Measured value: 667 g / mol)

[합성예 44] Inv-44의 합성Synthesis Example 44 Synthesis of Inv-44

Figure PCTKR2015000699-appb-I000148
Figure PCTKR2015000699-appb-I000148

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BTC-5와 4-Bromo-benzonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-44 (4.39, 64 %)를 얻었다.Except for using BTC-5 and 4-Bromo-benzonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out to obtain Inv-44 (4.39, 64%).

GC-Mass (이론치: 644.79 g/mol, 측정치: 644 g/mol)GC-Mass (Theoretical value: 644.79 g / mol, Measured value: 644 g / mol)

[합성예 45] Inv-45의 합성Synthesis Example 45 Synthesis of Inv-45

Figure PCTKR2015000699-appb-I000149
Figure PCTKR2015000699-appb-I000149

PC-1 대신 BTC-5를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-45 (4.83, 63 %)를 얻었다.Except for using BTC-5 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-45 (4.83, 63%).

GC-Mass (이론치: 720.88 g/mol, 측정치: 720 g/mol)GC-Mass (Theoretical value: 720.88 g / mol, Measured value: 720 g / mol)

[합성예 46] Inv-46의 합성Synthesis Example 46 Synthesis of Inv-46

Figure PCTKR2015000699-appb-I000150
Figure PCTKR2015000699-appb-I000150

PC-1 대신 BTC-6를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-46 (4.75, 62 %)를 얻었다.Except for using BTC-6 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-46 (4.75, 62%).

GC-Mass (이론치: 720.88 g/mol, 측정치: 720 g/mol)GC-Mass (Theoretical value: 720.88 g / mol, Measured value: 720 g / mol)

[합성예 47] Inv-47의 합성Synthesis Example 47 Synthesis of Inv-47

Figure PCTKR2015000699-appb-I000151
Figure PCTKR2015000699-appb-I000151

PC-1과 3'-Bromo-biphenyl-4-carbonitrile 대신 BOC-7과 4-Bromo-benzonitrile를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-47 (4.66, 64 %)를 얻었다.Except for using BOC-7 and 4-Bromo-benzonitrile instead of PC-1 and 3'-Bromo-biphenyl-4-carbonitrile, the same procedure as in Synthesis Example 1 was carried out to obtain Inv-47 (4.66, 64%).

GC-Mass (이론치: 684.86 g/mol, 측정치: 684 g/mol)GC-Mass (Theoretical value: 684.86 g / mol, Measured value: 684 g / mol)

[합성예 48] Inv-48의 합성Synthesis Example 48 Synthesis of Inv-48

Figure PCTKR2015000699-appb-I000152
Figure PCTKR2015000699-appb-I000152

PC-1 대신 BTC-8를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-48 (3.72, 46 %)를 얻었다.Except for using BTC-8 instead of PC-1 was carried out the same procedure as in Synthesis Example 1 to obtain the target compound Inv-48 (3.72, 46%).

GC-Mass (이론치: 760.95 g/mol, 측정치: 760 g/mol)GC-Mass (Theoretical value: 760.95 g / mol, Measured value: 760 g / mol)

[실시예 1 내지 48] 녹색 유기 전계 발광 소자의 제조Examples 1 to 48 Fabrication of Green Organic Electroluminescent Devices

합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 소자를 제조하였다.The compound synthesized in Synthesis Example was subjected to high purity sublimation purification by a conventionally known method, and the device was manufactured according to the following procedure.

먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) having a thickness of 1500 된 was ultrasonically washed with distilled water. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech) and then the substrate is cleaned for 5 minutes using UV and vacuum evaporator. The substrate was transferred.

이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ 90% Inv-1 내지 Inv-48 각각의 화합물 + 10 % Ir(ppy)3 (30 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 소자를 제조하였다.M-MTDATA (60 nm) / TCTA (80 nm) / 90% Inv-1 to Inv-48 compound + 10% Ir (ppy) 3 (30 nm) / BCP (ITO transparent substrate (electrode) thus prepared) 10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) was laminated in order to manufacture a device.

[비교예 1] 녹색 유기 전계 발광 소자의 제조Comparative Example 1 Fabrication of Green Organic Electroluminescent Device

발광층 형성시 발광 호스트 물질로서 화합물 Inv-1 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 소자를 제조하였다.A device was manufactured in the same manner as in Example 1, except for using CBP instead of the compound Inv-1 as a light emitting host material when forming the emission layer.

상기 실시예 1 내지 48 및 비교예 1에서 사용된 m-MTDATA, TCTA, Ir(ppy)3, BCP 및 CBP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , BCP and CBP used in Examples 1 to 48 and Comparative Example 1 are as follows.

Figure PCTKR2015000699-appb-I000153
Figure PCTKR2015000699-appb-I000153

[평가예][Evaluation Example]

실시예 1 내지 48 및 비교예 1에서 제조한 각각의 녹색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.For each of the green organic electroluminescent devices prepared in Examples 1 to 48 and Comparative Example 1, the driving voltage, current efficiency, and emission peak at a current density of 10 mA / cm 2 were measured, and the results are shown in Table 1 below. .

표 1 샘플 호스트 구동전압(V) 발광피크(nm) 전류효율(cd/A) 실시예 1 Inv-1 6.66 516 42.6 실시예 2 Inv-2 6.91 517 39.4 실시예 3 Inv-3 6.85 516 38.8 실시예 4 Inv-4 6.86 516 43.5 실시예 5 Inv-5 6.91 517 42.1 실시예 6 Inv-6 6.85 516 42.6 실시예 7 Inv-7 6.63 515 39.4 실시예 8 Inv-8 6.75 515 38.8 실시예 9 Inv-9 6.85 516 40.9 실시예 10 Inv-10 6.63 517 42.1 실시예 11 Inv-11 6.75 516 42.6 실시예 12 Inv-12 6.73 517 39.4 실시예 13 Inv-13 6.75 515 38.8 실시예 14 Inv-14 6.63 516 40.9 실시예 15 Inv-15 6.75 517 41.2 실시예 16 Inv-16 6.73 516 39.2 실시예 17 Inv-17 6.75 517 41.1 실시예 18 Inv-18 6.81 517 42.0 실시예 19 Inv-19 6.89 517 41.1 실시예 20 Inv-20 6.81 518 40.9 실시예 21 Inv-21 6.64 516 41.7 실시예 22 Inv-22 6.66 516 41.3 실시예 23 Inv-23 6.69 516 42.2 실시예 24 Inv-24 6.83 516 41.5 실시예 25 Inv-25 6.69 517 39.8 실시예 26 Inv-26 6.65 515 40.5 실시예 27 Inv-27 6.68 516 40.9 실시예 28 Inv-28 6.61 518 41.1 실시예 29 Inv-29 6.73 517 40.9 실시예 30 Inv-30 6.73 516 41.8 실시예 31 Inv-31 6.68 518 41.3 실시예 32 Inv-32 6.62 516 42.8 실시예 33 Inv-33 6.61 516 41.3 실시예 34 Inv-34 6.83 516 39.8 실시예 35 Inv-35 6.72 517 41.3 실시예 36 Inv-36 6.69 516 42.2 실시예 37 Inv-37 6.65 517 41.3 실시예 38 Inv-38 6.68 517 39.8 실시예 39 Inv-39 6.61 518 40.5 실시예 40 Inv-40 6.73 516 40.9 실시예 41 Inv-41 6.68 516 40.9 실시예 42 Inv-42 6.62 518 39.8 실시예 43 Inv-43 6.61 516 40.5 실시예 44 Inv-44 6.82 517 40.9 실시예 45 Inv-45 6.85 517 38.9 실시예 46 Inv-46 6.63 516 42.0 실시예 47 Inv-47 6.68 517 41.3 실시예 48 Inv-48 6.91 518 39.8 비교예 1 CBP 6.93 516 38.1 Table 1 Sample Host Driving voltage (V) Light emitting peak (nm) Current efficiency (cd / A) Example 1 Inv-1 6.66 516 42.6 Example 2 Inv-2 6.91 517 39.4 Example 3 Inv-3 6.85 516 38.8 Example 4 Inv-4 6.86 516 43.5 Example 5 Inv-5 6.91 517 42.1 Example 6 Inv-6 6.85 516 42.6 Example 7 Inv-7 6.63 515 39.4 Example 8 Inv-8 6.75 515 38.8 Example 9 Inv-9 6.85 516 40.9 Example 10 Inv-10 6.63 517 42.1 Example 11 Inv-11 6.75 516 42.6 Example 12 Inv-12 6.73 517 39.4 Example 13 Inv-13 6.75 515 38.8 Example 14 Inv-14 6.63 516 40.9 Example 15 Inv-15 6.75 517 41.2 Example 16 Inv-16 6.73 516 39.2 Example 17 Inv-17 6.75 517 41.1 Example 18 Inv-18 6.81 517 42.0 Example 19 Inv-19 6.89 517 41.1 Example 20 Inv-20 6.81 518 40.9 Example 21 Inv-21 6.64 516 41.7 Example 22 Inv-22 6.66 516 41.3 Example 23 Inv-23 6.69 516 42.2 Example 24 Inv-24 6.83 516 41.5 Example 25 Inv-25 6.69 517 39.8 Example 26 Inv-26 6.65 515 40.5 Example 27 Inv-27 6.68 516 40.9 Example 28 Inv-28 6.61 518 41.1 Example 29 Inv-29 6.73 517 40.9 Example 30 Inv-30 6.73 516 41.8 Example 31 Inv-31 6.68 518 41.3 Example 32 Inv-32 6.62 516 42.8 Example 33 Inv-33 6.61 516 41.3 Example 34 Inv-34 6.83 516 39.8 Example 35 Inv-35 6.72 517 41.3 Example 36 Inv-36 6.69 516 42.2 Example 37 Inv-37 6.65 517 41.3 Example 38 Inv-38 6.68 517 39.8 Example 39 Inv-39 6.61 518 40.5 Example 40 Inv-40 6.73 516 40.9 Example 41 Inv-41 6.68 516 40.9 Example 42 Inv-42 6.62 518 39.8 Example 43 Inv-43 6.61 516 40.5 Example 44 Inv-44 6.82 517 40.9 Example 45 Inv-45 6.85 517 38.9 Example 46 Inv-46 6.63 516 42.0 Example 47 Inv-47 6.68 517 41.3 Example 48 Inv-48 6.91 518 39.8 Comparative Example 1 CBP 6.93 516 38.1

상기 표 1에 나타낸 바와 같이, 본 발명에 따른 화합물을 녹색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 1 내지 48)가 종래의 CBP를 사용한 경우(비교예 1)보다 효율 및 구동전압이 우수한 것을 확인할 수 있다.As shown in Table 1, when the compound according to the present invention is used for the light emitting layer of the green organic electroluminescent device (Examples 1 to 48), the efficiency and driving voltage are superior to those when using the conventional CBP (Comparative Example 1). You can see that.

본 발명의 화합물은 열적 안정성, 전자 및 정공 수송능, 발광능 등이 우수하기 때문에 유기 전계 발광 소자의 유기물층 재료로 유용하게 적용될 수 있다.Since the compound of the present invention has excellent thermal stability, electron and hole transport ability, light emitting ability, and the like, it can be usefully applied as an organic material layer material of an organic EL device.

또한 본 발명의 화합물을 유기물층에 포함하는 유기 전계 발광 소자는 발광성능, 구동전압, 수명, 효율 등의 측면이 크게 향상되어 풀 칼라 디스플레이 패널 등에 효과적으로 적용될 수 있다.In addition, the organic electroluminescent device including the compound of the present invention in the organic material layer can be effectively applied to a full color display panel since the aspects such as light emission performance, driving voltage, lifetime, and efficiency are greatly improved.

Claims (9)

하기 화학식 1로 표시되는 화합물:Compound represented by the following formula (1): [화학식 1][Formula 1]
Figure PCTKR2015000699-appb-I000154
Figure PCTKR2015000699-appb-I000154
상기 화학식 1에서,In Chemical Formula 1, X1은 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고,X 1 is selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ), X2 및 X3는 각각 독립적으로, N 또는 C(R2)이며, X 2 and X 3 are each independently N or C (R 2 ), Y1 내지 Y4는 각각 독립적으로, N 또는 C(R1)이되, Y1과 Y2, Y2와 Y3 및 Y3와 Y4 중 적어도 하나는 하기 화학식 2로 표시되는 축합 고리를 형성하고,Y 1 to Y 4 are each independently N or C (R 1 ), and at least one of Y 1 and Y 2 , Y 2 and Y 3, and Y 3 and Y 4 forms a condensed ring represented by Formula 2 below. and, [화학식 2][Formula 2]
Figure PCTKR2015000699-appb-I000155
Figure PCTKR2015000699-appb-I000155
상기 화학식 2에서,In Chemical Formula 2, 점선은 상기 화학식 1의 화합물과 결합되는 부분이고,Dotted line is a portion that is bonded to the compound of Formula 1, X4는 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고,X 4 is selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ), Y5 내지 Y8은 각각 독립적으로, N 또는 C(R3)이고,Y 5 to Y 8 are each independently N or C (R 3 ), 상기 X1 및 X4 중 적어도 하나는 N(Ar1)이며,At least one of X 1 and X 4 is N (Ar 1 ), 상기 R1 내지 R3 및 Ar1 내지 Ar5는 각각 독립적으로, 수소, 중수소, 할로겐기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C1~C40의 포스핀기, C1~C40의 포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 이때, R1 내지 R3 및 Ar1 내지 Ar5 중 적어도 하나는 시아노기가 치환된 C6~C60의 아릴기 또는 시아노기가 치환된 핵원자수 5 내지 60의 헤테로아릴기이며,Wherein R 1 to R 3 and Ar 1 to Ar 5 are each independently, hydrogen, deuterium, halogen group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 to C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 to C 40 Alkyloxy group, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 the arylboronic group, C 1 ~ C 40 of the phosphine group, is selected from the group consisting of an aryl amine of the C 1 ~ C 40 phosphine oxide group, and a C 6 ~ C 60 of the, at this time, R 1 to R 3 and Ar 1 At least one of Ar 5 is a C 6 ~ C 60 Aryl group substituted with a cyano group or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group, 상기 R1 내지 R3는 인접한 기와 축합 고리를 형성 또는 비형성하고,R 1 to R 3 form or not form a condensed ring with an adjacent group, 상기 R1 내지 R3 및 Ar1 내지 Ar5의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 포스핀기, 포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C1~C40의 포스핀기, C1~C40의 포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환 또는 비치환된다.The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group of R 1 to R 3 and Ar 1 to Ar 5 , Alkyl boron group, aryl boron group, phosphine group, phosphine oxide group and arylamine group are each independently deuterium, halogen group, nitro group, amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group , C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 Cycloalkyl group, C 3 ~ C 40 heterocycloalkyl group, C 6 ~ C 60 Aryl group, Nuclear atoms 5 to 60 heteroaryl group, C 1 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 1 -C 40 alkylsilyl group, C 6 -C 60 arylsilyl group, C 1 -C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 1 ~ C 40 of the phosphine group, C 1 ~ C 40 phosphine oxide group, and a C 6 ~ substituted by one or more selected from the group consisting of an aryl amine of the C 60 of the Or unsubstituted.
제1항에 있어서,The method of claim 1, 상기 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택되는 화합물.Compound represented by the formula (1) is a compound selected from the group consisting of compounds represented by the following formula 1a to 1f. [화학식 1a][Formula 1a]
Figure PCTKR2015000699-appb-I000156
Figure PCTKR2015000699-appb-I000156
[화학식 1b][Formula 1b]
Figure PCTKR2015000699-appb-I000157
Figure PCTKR2015000699-appb-I000157
[화학식 1c][Formula 1c]
Figure PCTKR2015000699-appb-I000158
Figure PCTKR2015000699-appb-I000158
[화학식 1d][Formula 1d]
Figure PCTKR2015000699-appb-I000159
Figure PCTKR2015000699-appb-I000159
[화학식 1e][Formula 1e]
Figure PCTKR2015000699-appb-I000160
Figure PCTKR2015000699-appb-I000160
[화학식 1f][Formula 1f]
Figure PCTKR2015000699-appb-I000161
Figure PCTKR2015000699-appb-I000161
상기 화학식 1a 내지 1f에서,In Chemical Formulas 1a to 1f, X1 내지 X4 및 Y1 내지 Y8은 제1항에서 정의한 바와 같다.X 1 to X 4 and Y 1 to Y 8 are as defined in claim 1.
제1항에 있어서,The method of claim 1, 상기 화학식 1로 표시되는 화합물은 하기 화학식 B-1 내지 B-30으로 표시되는 화합물로 이루어진 군에서 선택되는 화합물.The compound represented by Formula 1 is a compound selected from the group consisting of compounds represented by the following formulas B-1 to B-30.
Figure PCTKR2015000699-appb-I000162
Figure PCTKR2015000699-appb-I000162
상기 화학식 B-1 내지 B-30에서,In Chemical Formulas B-1 to B-30, Ar1 및 R1 내지 R3는 제1항에서 정의한 바와 같으며,Ar 1 and R 1 to R 3 are as defined in claim 1, 복수의 R1은 서로 동일하거나 상이하고, 복수의 R2는 서로 동일하거나 상이하며, 복수의 R3는 서로 동일하거나 상이하다.A plurality of R 1 are the same or different from each other, a plurality of R 2 are the same or different from each other, and a plurality of R 3 are the same or different from each other.
제1항에 있어서,The method of claim 1, 상기 Ar1은 시아노기가 치환된 C6~C60의 아릴기, 또는 시아노기가 치환된 핵원자수 5 내지 60의 헤테로아릴기인 화합물.Ar 1 is a C 6 ~ C 60 aryl group substituted with a cyano group, or a heteroaryl group having 5 to 60 nuclear atoms substituted with a cyano group. 제1에 있어서,According to the first, Ar1 내지 Ar5는 각각 독립적으로 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴아민기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되는 화합물.Ar 1 to Ar 5 are each independently a group consisting of a C 6 ~ C 60 aryl group, a heteroaryl group of 5 to 60 nuclear atoms, a C 6 ~ C 60 arylamine group and a C 6 ~ C 60 arylsilyl group Compound selected from. 제1항에 있어서,The method of claim 1, 상기 R1 내지 R3는 각각 독립적으로 수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 화합물. R 1 to R 3 are each independently hydrogen, halogen, cyano group, C 1 ~ C 40 alkyl group, C 6 ~ C 60 aryl group, nuclear atoms 5 to 60 heteroaryl group and C 6 ~ C 60 A compound selected from the group consisting of arylamine groups. 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서,An organic electroluminescent device comprising an anode, a cathode, and at least one organic material layer interposed between the anode and the cathode. 상기 1층 이상의 유기물층 중 적어도 하나는 제1항 내지 제6항 중 어느 한 항에 기재된 화합물을 포함하는 유기 전계 발광 소자.At least one of the one or more organic material layers is an organic electroluminescent device comprising the compound according to any one of claims 1 to 6. 제7항에 있어서,The method of claim 7, wherein 상기 화합물을 포함하는 유기물층은 정공주입층, 정공수송층, 전자수송층, 전자주입층 및 발광층으로 이루어진 군에서 선택되는 유기 전계 발광 소자.The organic material layer containing the compound is an organic electroluminescent device selected from the group consisting of a hole injection layer, a hole transport layer, an electron transport layer, an electron injection layer and a light emitting layer. 제8항에 있어서,The method of claim 8, 상기 화합물을 포함하는 유기물층은 발광층이며,The organic material layer containing the compound is a light emitting layer, 상기 화합물은 상기 발광층의 인광 호스트인 유기 전계 발광 소자.The compound is an organic electroluminescent device which is a phosphorescent host of the light emitting layer.
PCT/KR2015/000699 2014-01-23 2015-01-23 Organic compound and organic electroluminescent element comprising same Ceased WO2015111942A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2014-0008296 2014-01-23
KR1020140008296A KR101641409B1 (en) 2014-01-23 2014-01-23 Organic compounds and organic electro luminescence device comprising the same

Publications (2)

Publication Number Publication Date
WO2015111942A2 true WO2015111942A2 (en) 2015-07-30
WO2015111942A3 WO2015111942A3 (en) 2015-10-01

Family

ID=53682074

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/000699 Ceased WO2015111942A2 (en) 2014-01-23 2015-01-23 Organic compound and organic electroluminescent element comprising same

Country Status (2)

Country Link
KR (1) KR101641409B1 (en)
WO (1) WO2015111942A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042814A1 (en) * 2021-09-16 2023-03-23 株式会社Kyulux Compound, light-emitting material and light-emitting element
CN116693550A (en) * 2023-06-07 2023-09-05 浙江八亿时空先进材料有限公司 A kind of oxazole derivative and its application

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170016701A (en) * 2015-08-04 2017-02-14 주식회사 두산 Organic light-emitting compound and organic electroluminescent device using the same
KR102209930B1 (en) * 2018-02-23 2021-02-01 주식회사 엘지화학 Spiro compound and organic light emitting device comprising the same
KR102568928B1 (en) * 2020-12-14 2023-08-22 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same
US20240057477A1 (en) * 2020-12-17 2024-02-15 Lg Chem, Ltd. Novel compound and organic light emitting device comprising the same
KR102576738B1 (en) * 2020-12-17 2023-09-08 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same
CN116917292A (en) * 2021-08-04 2023-10-20 株式会社Lg化学 New compounds and organic light-emitting devices containing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110066763A (en) 2009-12-11 2011-06-17 덕산하이메탈(주) Compound containing indolo acridine and organic electric device using the same, the terminal
WO2013085339A2 (en) * 2011-12-07 2013-06-13 주식회사 두산 Organic light-emitting compound and organic electroluminescent device using same
WO2013122364A2 (en) * 2012-02-13 2013-08-22 덕산하이메탈(주) Compound for organic electrical element, organic electrical element comprising same, and electronic device therewith
KR102169443B1 (en) * 2012-04-10 2020-10-23 에스에프씨 주식회사 Heterocyclic com pounds and organic light-emitting diode including the same
KR101477344B1 (en) * 2012-07-09 2014-12-29 주식회사 두산 Novel compound and organic electroluminescent device comprising the same
KR101507421B1 (en) * 2012-07-12 2015-04-08 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042814A1 (en) * 2021-09-16 2023-03-23 株式会社Kyulux Compound, light-emitting material and light-emitting element
CN116693550A (en) * 2023-06-07 2023-09-05 浙江八亿时空先进材料有限公司 A kind of oxazole derivative and its application

Also Published As

Publication number Publication date
KR20150088007A (en) 2015-07-31
KR101641409B1 (en) 2016-07-20
WO2015111942A3 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
WO2017179809A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2016089080A1 (en) Organic luminescent compound and organic electroluminescent device comprising same
WO2018038401A1 (en) Organic compound and organic electroluminescence device including same
WO2013094999A2 (en) Organic compound, and organic electroluminescent device using same
WO2018110958A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2018093107A1 (en) Organic compound and organic electroluminescent element comprising same
WO2014010810A1 (en) Novel compound and electroluminescent device including same
WO2014142488A1 (en) Organic compound and organic electroluminescent element including same
WO2014092354A1 (en) Organic compound and organic electroluminescent element comprising same
WO2015111942A2 (en) Organic compound and organic electroluminescent element comprising same
WO2014065498A1 (en) Organic electroluminescent device
WO2020027463A1 (en) Organic compound and organic electroluminescent device using same
WO2020209679A1 (en) Organic compound and organic electroluminescent element comprising same
WO2018038400A1 (en) Organic compound and organic electroluminescence device including same
WO2016105123A2 (en) Organic compound and organic electroluminescent device comprising same
WO2014027822A1 (en) Novel compound and organic electroluminescent device comprising same
WO2016105054A2 (en) Organic light emitting compound and organic electroluminescent element using same
WO2018038464A1 (en) Organic compound and organic electroluminescent device comprising same
WO2018212463A1 (en) Organic light-emitting compound, and organic electroluminescent element using same
WO2015111943A1 (en) Organic compound, and organic electroluminescent device containing same
WO2014027814A1 (en) Novel compound and organic electroluminescent device comprising same
WO2014025114A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2015125986A1 (en) Organic compound and organic electroluminescent device comprising same
WO2014046392A1 (en) Organic compound and electroluminescent element having same
WO2015133808A1 (en) Organic compound and organic electroluminescent device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15739853

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 29.09.2016)

122 Ep: pct application non-entry in european phase

Ref document number: 15739853

Country of ref document: EP

Kind code of ref document: A2